Tail nerve electrical stimulation combined with scar ablation and neural transplantation promotes locomotor recovery in rats with chronically contused spinal cord ☆ Shu-xin Zhanga , , Fengfa Huanga , Mary Gatesa , Eric G. Holmberga , b To date , few treatment strategies applying cellular transplantation to the chronically injured spinal cord	1
Tail nerve	1
electrical stimulation combined with scar ablation and neural transplantation	12
electrical stimulation	12
scar ablation and neural transplantation	49
scar ablation	49
neural transplantation	67
locomotor recovery	99
rats with chronically contused spinal cord ☆ Shu-xin Zhanga , , Fengfa Huanga , Mary Gatesa , Eric G. Holmberga , b To date , few treatment strategies applying cellular transplantation to the chronically injured spinal cord	121
rats	121
chronically contused spinal cord ☆ Shu-xin Zhanga , , Fengfa Huanga , Mary Gatesa , Eric G. Holmberga , b To date , few treatment strategies applying cellular transplantation to the chronically injured spinal cord	131
spinal cord ☆ Shu-xin Zhanga , , Fengfa Huanga , Mary Gatesa , Eric G. Holmberga , b To date , few treatment strategies applying cellular transplantation to the chronically injured spinal cord	152
spinal cord ☆ Shu-xin Zhanga	152
Fengfa Huanga , Mary Gatesa , Eric G. Holmberga , b To date	183
Fengfa Huanga	183
Mary Gatesa	198
Eric G. Holmberga	211
b To date	229
few treatment strategies applying cellular transplantation to the chronically injured spinal cord	241
few treatment strategies	241
cellular transplantation	275
the chronically injured spinal cord	303
significant functional improvement	352
animal experiments	390
we	415
significant improvement of locomotor function	430
significant improvement	430
locomotor function	457
rats with chronic spinal cord injury -LRB- SCI -RRB-	492
rats	492
chronic spinal cord injury -LRB- SCI -RRB-	502
chronic spinal cord injury	502
SCI	530
the application of combination treatments with tail nerve electrical stimulation -LRB- TANES -RRB- , which can activate the central pattern generator , inducing active weight-supported stepping	538
the application of combination treatments with tail nerve electrical stimulation -LRB- TANES -RRB-	538
the application	538
combination treatments with tail nerve electrical stimulation	557
combination treatments	557
tail nerve electrical stimulation	585
TANES	620
the central pattern generator	647
active	687
Contusion injury -LRB- 25 mm -RRB- to spinal cord T10	721
Contusion injury -LRB- 25 mm -RRB-	721
Contusion injury	721
25 mm	739
spinal cord T10	749
the NYU impactor device	787
female , adult Long -- Evans rats	814
female , adult Long	814
Evans rats	834
Rats in 2 of 4 groups with SCI	846
Rats	846
2 of 4 groups with SCI	854
2	854
4 groups with SCI	859
4 groups	859
SCI	873
basic treatments -LRB- scar ablation followed by transplantation of lamina propria of olfactory mucosa and cultured olfactory ensheathing cells into the lesion cavity -RRB-	886
basic treatments	886
scar ablation followed by transplantation of lamina propria of olfactory mucosa and cultured olfactory ensheathing cells into the lesion cavity	904
scar ablation	904
transplantation of lamina propria of olfactory mucosa	930
transplantation	930
lamina propria of olfactory mucosa	949
lamina propria	949
olfactory mucosa	967
olfactory ensheathing cells	997
the lesion cavity	1030
6 weeks	1049
SCI	1063
Rats both with and without basic treatments	1068
Rats both	1068
Rats	1068
basic treatments	1095
one week after secondary surgery or 7 weeks	1136
one week	1136
secondary surgery or 7 weeks	1151
secondary surgery	1151
7 weeks	1172
SCI	1186
Sixteen weeks after secondary surgery or 22 weeks after SCI rats in two groups receiving TANES	1191
Sixteen weeks	1191
secondary surgery	1211
22 weeks	1232
SCI rats in two groups	1247
SCI rats	1247
two groups	1259
TANES	1280
their functional recovery	1309
those without TANES	1349
those	1349
TANES	1363
BBB	1390
open field rating scale -LRB- p < 0.01 -RRB-	1394
open field rating scale	1394
p < 0.01	1419
p	1419
< 0.01	1420
<	1420
0.01	1421
them , however	1434
them	1434
rats with basic treatments	1449
rats	1449
basic treatments	1459
better	1486
those	1498
basic treatments	1512
TANES	1530
the activity-dependent plasticity	1554
the injury level , which is critical for functional recovery	1594
the injury level	1594
functional recovery	1634
TANES	1669
axonal regeneration , including those from supraspinal level	1687
axonal regeneration	1687
those from supraspinal level	1718
those	1718
supraspinal level	1729
TANES	1754
considerable potential	1773
improvement of functional recovery	1810
improvement	1810
functional recovery	1825
rat model	1848
it	1859
a new strategy for chronic SCI	1876
a new strategy	1876
chronic SCI	1895
Introduction	1912
few treatment strategies	1932
cellular transplantation	1966
the chronically injured	1994
spinal cord	2040
significant functional improvement	2065
animal experiments -LRB- Barakat et al. , 2005 ; Tetzlaff et al. , 2011 -RRB-	2103
animal experiments	2103
Barakat	2123
et al. , 2005 ; Tetzlaff et al. , 2011	2131
et al.	2131
2005 ; Tetzlaff et al.	2139
2005	2139
Tetzlaff et al.	2145
Tetzlaff	2145
et al.	2154
2011	2162
the cellular transplantation	2181
therapies , lamina propria -LRB- LP -RRB-	2210
therapies	2210
lamina propria -LRB- LP -RRB-	2221
lamina propria	2221
LP	2237
derived olfactory ensheathing cells -LRB- OECs -RRB- and LP	2241
derived olfactory ensheathing cells -LRB- OECs -RRB-	2241
derived olfactory ensheathing cells	2241
OECs	2278
LP	2288
leading cell or tissue candidates for transplantation	2315
leading cell or tissue candidates	2315
transplantation	2353
the gap in injured spinal cord due to their potential reparative properties and function -LRB- Boyd et al. , 2005 ; Lima et al. , 2009 ; Mackay-Sim et al. , 2008 ; Richter et al. , 2005 -RRB-	2379
the gap	2379
injured spinal cord due to their potential reparative properties and function -LRB- Boyd et al. , 2005 ; Lima et al. , 2009 ; Mackay-Sim et al. , 2008 ; Richter et al. , 2005 -RRB-	2390
injured spinal cord due to their potential reparative properties and function	2390
injured spinal cord	2390
their potential reparative properties and function	2417
Boyd et al. , 2005 ; Lima et al. , 2009 ; Mackay-Sim et al. , 2008 ; Richter et al. , 2005	2469
Boyd	2469
et al. , 2005 ; Lima et al. , 2009 ; Mackay-Sim et al. , 2008 ; Richter et al. , 2005	2474
et al. , 2005	2474
et al.	2474
2005	2482
Lima et al. , 2009	2488
Lima	2488
et al. , 2009	2493
et al.	2493
2009	2501
Mackay-Sim et al. , 2008	2507
Mackay-Sim	2507
et al. , 2008	2518
et al.	2518
2008	2526
Richter et al. , 2005	2532
Richter	2532
et al. , 2005	2540
et al.	2540
2005	2548
our previous studies	2558
we	2580
an existing glial scar in chronically contused rat spinal cord	2604
an existing glial scar	2604
chronically contused rat spinal cord	2630
a rose Bengal-based phototoxic ablation method -LRB- Zhang et al. , 2007a -RRB-	2676
a rose Bengal-based phototoxic ablation method	2676
a rose	2676
Bengal-based phototoxic ablation method	2683
Zhang	2724
et al. , 2007a	2730
et al.	2730
2007a	2738
we	2756
the LP	2772
combination	2782
OEC	2808
the lesion cavity	2817
scar ablation	2853
Sixteen weeks	2868
combination treatment	2888
substantial tissue repair of damaged cord at the injury epicenter	2911
substantial tissue repair	2911
damaged cord at the injury epicenter	2940
damaged cord	2940
the injury epicenter	2956
1 -RRB- prominent development of endogenous repaired tissue , 2 -RRB- disappearance of the lesion cavity , and 3 -RRB- integration of the repaired tissue with spared tissue	3005
1 -RRB- prominent development of endogenous repaired tissue	3005
prominent development	3008
endogenous repaired tissue	3033
endogenous	3033
tissue	3053
2 -RRB- disappearance of the lesion cavity	3061
disappearance	3064
the lesion cavity	3081
3 -RRB- integration of the repaired tissue with spared tissue	3104
integration	3107
the repaired tissue with spared tissue	3122
the repaired tissue	3122
spared tissue	3147
Anatomical tissue repair	3162
a more permissive environment for the axons to robustly grow into and beyond the injury site.However , remarkable tissue repair and axonal regeneration	3196
a more permissive environment	3196
the axons	3230
the injury site.However , remarkable tissue repair and axonal regeneration	3273
the injury site.However	3273
remarkable tissue repair	3298
axonal regeneration	3327
significant locomotor recovery -LRB- Zhang et al. , 2011a -RRB-	3365
significant locomotor recovery	3365
Zhang	3397
et al. , 2011a	3403
et al.	3403
2011a	3411
themain reasonmay	3419
the poor intrinsic , activity-dependent plasticity induced by locomotor training below the injury level of the spinal cord	3454
the poor intrinsic , activity-dependent plasticity	3454
locomotor training	3515
the injury level of the spinal cord	3540
the injury level	3540
the spinal cord	3560
It	3577
gait	3607
sensory inputs and independently a central pattern generator -LRB- CPG -RRB- -LRB- Ekeberg and Pearson , 2005 -RRB- , therefore the sensory information is a necessary component for locomotor pattern generation -LRB- Norton and Mushahwar , 2010 -RRB-	3639
sensory inputs and independently a central pattern generator -LRB- CPG -RRB-	3639
sensory inputs	3639
a central pattern generator -LRB- CPG -RRB-	3672
a central pattern generator	3672
CPG	3701
Ekeberg and Pearson , 2005 -RRB- , therefore the sensory information is a necessary component for locomotor pattern generation -LRB- Norton and Mushahwar , 2010	3707
Ekeberg and Pearson , 2005 -RRB-	3707
Ekeberg and Pearson	3707
Ekeberg	3707
Pearson	3719
2005	3728
the sensory information	3745
a necessary component	3772
locomotor pattern generation -LRB- Norton and Mushahwar , 2010	3798
locomotor pattern generation -LRB- Norton and Mushahwar	3798
locomotor pattern generation	3798
Norton and Mushahwar	3828
Norton	3828
Mushahwar	3839
2010	3850
SCI	3867
plasticity below the lesion level of the spinal cord	3872
plasticity	3872
the lesion level of the spinal cord	3889
the lesion level	3889
the spinal cord	3909
place	3931
the optimization of the CPG expression ; plastic changes in descending systems ensure that these systems can exert a new dynamical control on the spinal CPG -LRB- Rossignol et al. , 2007 -RRB-	3947
the optimization of the CPG expression	3947
the optimization	3947
the CPG expression	3967
plastic changes in descending systems ensure that these systems can exert a new dynamical control on the spinal CPG -LRB- Rossignol et al. , 2007 -RRB-	3987
plastic changes	3987
systems	4017
these systems	4037
a new dynamical control	4061
the spinal CPG -LRB- Rossignol et al. , 2007 -RRB-	4088
the spinal CPG	4088
Rossignol	4103
et al. , 2007	4113
et al.	4113
2007	4121
the spontaneous plasticity	4137
both the supraspinal and spinal levels	4174
SCI	4219
it	4224
functional recovery	4261
CPG-mediated plasticity	4287
functional recovery	4328
physical therapy	4373
rehabilitation approaches	4401
locomotor training	4451
techniques	4476
voluntary aspects of locomotion	4505
voluntary aspects	4505
locomotion	4526
endogenous spinal mechanisms -LRB- Rossignol et al. , 2007 -RRB-	4561
endogenous spinal mechanisms	4561
Rossignol	4591
et al. , 2007	4601
et al.	4601
2007	4609
Physical therapy	4616
a necessary mean for the combining treatment of chronic spinal cord injury to improve the functional recovery in both animal experiments and clinical trials -LRB- Behrman and Harkema , 2000 ; Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al. , 2007b -RRB-	4656
a necessary mean	4656
the combining treatment of chronic spinal cord injury to improve the functional recovery in both animal experiments and clinical trials -LRB- Behrman and Harkema , 2000 ; Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al. , 2007b -RRB-	4677
the combining treatment	4677
chronic spinal cord injury	4704
the functional recovery in both animal experiments and clinical trials -LRB- Behrman and Harkema , 2000 ; Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al. , 2007b -RRB-	4742
the functional recovery	4742
both animal experiments and clinical trials	4769
animal experiments	4774
clinical trials	4797
Behrman and Harkema , 2000 ; Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al. , 2007b	4814
Behrman and Harkema	4814
2000 ; Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al.	4835
2000	4835
Dobkin et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al.	4841
Dobkin	4841
et al. , 2007 ; Johston , 2001 ; Stevens et al. , 2006 ; Zhang et al.	4848
et al. , 2007	4848
et al.	4848
2007	4856
Johston , 2001	4862
Johston	4862
2001	4871
Stevens et al. , 2006	4877
Stevens	4877
et al. , 2006	4885
et al.	4885
2006	4893
Zhang et al.	4899
Zhang	4899
et al.	4905
2007b	4913
Evidence	4921
thatmovement of hind-limbs	4940
thatmovement	4940
hind-limbs	4956
the levels of NT-3 and BDNF	4980
the levels	4980
NT-3 and BDNF	4994
the motor neurons and muscle fibers	5011
the formation	5058
the dendritic tree and the plasticity of synaptic connection	5075
the dendritic tree	5075
the plasticity of synaptic connection	5098
the plasticity	5098
synaptic connection	5116
axonal regeneration	5145
the levels of inhibitory molecules -LRB- Gazula et al. , 2004 ; Ghiani et al. , 2007 ; Vaynman et al. , 2003 , 2006 ; Wirz et al. , 2001 ; Ying et al. , 2003 , 2005 -RRB-	5177
the levels	5177
inhibitory molecules -LRB- Gazula et al. , 2004 ; Ghiani et al. , 2007 ; Vaynman et al. , 2003 , 2006 ; Wirz et al. , 2001 ; Ying et al. , 2003 , 2005 -RRB-	5191
inhibitory molecules	5191
Gazula	5213
et al. , 2004 ; Ghiani et al. , 2007 ; Vaynman et al. , 2003 , 2006 ; Wirz et al. , 2001 ; Ying et al. , 2003 , 2005	5220
et al. , 2004 ; Ghiani et al. , 2007 ; Vaynman et al.	5220
et al. , 2004	5220
et al.	5220
2004	5228
Ghiani et al. , 2007	5234
Ghiani	5234
et al. , 2007	5241
et al.	5241
2007	5249
Vaynman et al.	5255
Vaynman	5255
et al.	5263
2003 , 2006 ; Wirz et al. , 2001 ; Ying et al.	5271
2003 , 2006	5271
2003	5271
2006	5277
Wirz et al. , 2001	5282
Wirz	5282
et al. , 2001	5287
et al.	5287
2001	5295
Ying et al.	5301
Ying	5301
et al.	5306
2003 , 2005	5314
2003	5314
2005	5320
fact	5330
the application of physical therapy in clinical trials and animal experiments	5336
the application	5336
physical therapy in clinical trials and animal experiments	5355
physical therapy	5355
clinical trials and animal experiments	5375
more and more attention -LRB- Lima et al. , 2009 ; Tillakaratne et al. , 2010 -RRB-	5428
more and more attention	5428
Lima	5453
et al. , 2009 ; Tillakaratne et al. , 2010	5458
et al.	5458
2009 ; Tillakaratne et al.	5466
2009	5466
Tillakaratne et al.	5472
Tillakaratne	5472
et al.	5485
2010	5493
Functional electrical stimulation-based physical therapy	5500
Functional	5500
electrical stimulation-based physical therapy	5511
chronic SCI treatment	5579
decades in both clinical trials and animal experiments	5605
decades	5605
both clinical trials and animal experiments	5616
both clinical trials	5616
animal experiments	5641
a long history of safe use	5665
a long history	5665
safe use	5683
no major clinical problems	5697
Barbeau and Rossignol , 1994 ; Barbeau et al. , 2002 ; Edgerton et al. , 2004 ; Hentall et al. , 2007 ; Hesse et al. , 2004 ; Johnston , 2006 ; Rossignol et al. , 1996	5748
Barbeau and Rossignol	5748
1994 ; Barbeau et al. , 2002 ; Edgerton et al. , 2004 ; Hentall et al. , 2007 ; Hesse et al. , 2004 ; Johnston , 2006 ; Rossignol et al.	5771
1994	5771
Barbeau et al. , 2002 ; Edgerton et al. , 2004 ; Hentall et al. , 2007 ; Hesse et al. , 2004 ; Johnston , 2006 ; Rossignol et al.	5777
Barbeau	5777
et al. , 2002 ; Edgerton et al. , 2004 ; Hentall et al. , 2007 ; Hesse et al. , 2004 ; Johnston , 2006 ; Rossignol et al.	5785
et al. , 2002	5785
et al.	5785
2002	5793
Edgerton et al. , 2004	5799
Edgerton	5799
et al. , 2004	5808
et al.	5808
2004	5816
Hentall et al. , 2007	5822
Hentall	5822
et al. , 2007	5830
et al.	5830
2007	5838
Hesse et al. , 2004	5844
Hesse	5844
et al. , 2004	5850
et al.	5850
2004	5858
Johnston , 2006	5864
Johnston	5864
2006	5874
Rossignol et al.	5880
Rossignol	5880
et al.	5890
1996	5898
none	5914
we	5960
a technique , tail nerve electrical stimulation -LRB- TANES -RRB- - dependent physical therapy , which can directly trigger the activation of the CPG below the lesion level through the tail nerves , resulting in temporary body weightsupported plantar stepping with characteristic features of active , alternative movement of left -- right hind limbs and coordination of front -- hind limbs in rats with chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	5973
a technique , tail nerve electrical stimulation -LRB- TANES -RRB-	5973
a technique , tail nerve electrical stimulation	5973
TANES	6021
dependent physical therapy , which can directly trigger the activation of the CPG below the lesion level through the tail nerves	6028
dependent physical therapy	6028
the activation of the CPG	6083
the activation	6083
the CPG	6101
the lesion level	6115
the tail nerves	6140
temporary body weightsupported plantar stepping with characteristic features of active , alternative movement of left -- right hind limbs and coordination of front -- hind limbs in rats with chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6170
temporary body weightsupported plantar stepping with characteristic features of active , alternative movement of left	6170
temporary body	6170
plantar stepping with characteristic features of active , alternative movement of left	6201
plantar	6201
characteristic features of active , alternative movement of left	6223
characteristic features	6223
active , alternative movement of left	6250
active , alternative movement	6250
right hind limbs and coordination of front -- hind limbs in rats with chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6287
right hind limbs	6287
coordination of front	6308
coordination	6308
front	6324
hind limbs in rats with chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6330
hind limbs	6330
rats with chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6344
rats	6344
chronically contused spinal cord -LRB- Zhang et al. , 2010 -RRB-	6354
chronically contused spinal cord	6354
Zhang	6388
et al. , 2010	6394
et al.	6394
2010	6402
This	6409
an early study in which the spinally transected rats were induced to exhibit a strong tendency to step with alternating limbs during tail pinch -LRB- Meisel and Rakerd , 1982 -RRB-	6428
an early study	6428
the spinally transected rats	6452
a strong tendency	6505
limbs	6548
tail pinch -LRB- Meisel and Rakerd , 1982 -RRB-	6561
tail pinch	6561
Meisel and Rakerd , 1982	6573
Meisel and Rakerd	6573
1982	6592
The TANES	6599
an effect	6623
that of epidural stimulation which enabled the SCI patient to achieve full weight-bear standing	6648
that	6648
epidural stimulation	6656
the SCI patient	6691
full weight-bear standing	6718
assistance	6762
stimulation -LRB- Harkema et al. , 2011 -RRB-	6780
stimulation	6780
Harkema	6793
et al. , 2011	6801
et al.	6801
2011	6809
The noninvasive TANES	6816
more beneficial effects	6852
locomotor training over other approaches such as treadmill training and functional electrical stimulation -LRB- de Leon et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998 -RRB-	6879
locomotor training	6879
other approaches such as treadmill training and functional electrical stimulation -LRB- de Leon et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998 -RRB-	6903
other approaches	6903
treadmill training and functional electrical stimulation -LRB- de Leon et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998 -RRB-	6928
treadmill training	6928
functional electrical stimulation -LRB- de Leon et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998 -RRB-	6951
functional electrical stimulation	6951
de Leon et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998	6986
de	6986
Leon et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998	6989
Leon	6989
et al. , 2002 ; Dietz et al. , 1997 ; Field - Fote , 2000 ; Gazula et al. , 2004 ; Hidler , 2004 ; Reinkensmeyer et al. , 2006 ; Van de Crommert et al. , 1998	6994
et al. , 2002	6994
et al.	6994
2002	7002
Dietz et al. , 1997	7008
Dietz	7008
et al. , 1997	7014
et al.	7014
1997	7022
Field - Fote , 2000	7028
Field	7028
Fote , 2000	7035
Fote	7035
2000	7041
Gazula et al. , 2004	7047
Gazula	7047
et al. , 2004	7054
et al.	7054
2004	7062
Hidler , 2004	7068
Hidler	7068
2004	7076
Reinkensmeyer et al. , 2006	7082
Reinkensmeyer	7082
et al. , 2006	7096
et al.	7096
2006	7104
Van de Crommert et al. , 1998	7110
Van de Crommert	7110
et al. , 1998	7126
et al.	7126
1998	7134
We	7141
TANES	7161
the activity-dependent plasticity via the activation of CPG , which would control the hind limb locomotion	7180
the activity-dependent plasticity	7180
the activation of CPG , which would control the hind limb locomotion	7218
the activation	7218
CPG	7236
the hind limb locomotion	7261
The main purpose of the study	7287
The main purpose	7287
the study	7307
the effects of TANES	7332
the effects	7332
TANES	7347
a locomotor training paradigm on functional recovery	7356
a locomotor training paradigm	7356
functional recovery	7389
the basic treatment which includes scar ablation and LP/OEC transplantation to chronically contused spinal cord of rats	7428
the basic treatment	7428
scar ablation and LP/OEC transplantation to chronically contused spinal cord of rats	7463
scar ablation and LP/OEC transplantation	7463
chronically contused spinal cord of rats	7507
chronically contused spinal cord	7507
rats	7543
Results Table 1 -- FB-labeled neurons in motor cortex and brainstem .	7553
Results Table 1	7553
Results	7553
Table 1	7561
FB-labeled neurons in motor cortex and brainstem	7571
FB-labeled neurons	7571
motor cortex and brainstem	7593
Fig. 1 -- Locomotor improvement by TANES .	7624
Fig. 1	7624
Locomotor improvement by TANES	7633
Locomotor improvement	7633
TANES	7658
Two or three weeks after TANES	7665
Two or three weeks	7665
TANES	7690
rats	7705
functional improvement	7724
the group	7750
basic treatments	7783
neither injury only control rats nor rats with basic treatments	7810
neither injury	7810
rats nor rats with basic treatments	7838
rats	7838
rats with basic treatments	7847
rats	7847
basic treatments	7857
notable improvement of functional recovery	7885
notable improvement	7885
functional recovery	7908
The difference of BBB scores between TANES rats and non-TANES rats	7929
The difference	7929
BBB scores between TANES rats and non-TANES rats	7947
BBB scores	7947
TANES rats and non-TANES rats	7966
TANES rats	7966
non-TANES rats	7981
p <	8028
p	8028
<	8029
0.01	8030
the end of this experiment	8039
the end	8039
this experiment	8050
0/6w : 6 weeks after contusion injury , i.e. , just before 2nd surgery ; 16/22	8067
0/6w	8067
6 weeks after contusion injury , i.e. , just before 2nd surgery	8073
6 weeks after contusion injury , i.e. ,	8073
6 weeks after contusion injury	8073
6 weeks	8073
contusion injury	8087
2nd surgery	8123
16/22	8136
16 weeks after 2nd surgery or 22 weeks after contusion injury	8143
16 weeks after 2nd surgery	8143
16 weeks	8143
2nd surgery	8158
22 weeks after contusion injury	8173
22 weeks	8173
contusion injury	8188
Fig. 2 -- Kinematic analysis of hind limb stepping cycle .	8207
Fig. 2	8207
Kinematic analysis of hind limb stepping cycle	8216
Kinematic analysis	8216
hind limb stepping cycle	8238
hind limb	8238
cycle	8257
A	8264
the bony landmarks of hind limbs related to the locomotion	8273
the bony landmarks	8273
hind limbs related to the locomotion	8295
hind limbs	8295
the locomotion	8317
B	8333
each phase of consecutive stepping cycles , which include the beginning phase , middle phase , ending phase , and middle swing , as well as the phase in stance	8342
each phase	8342
consecutive stepping cycles , which include the beginning phase , middle phase , ending phase , and middle swing , as well as the phase in stance	8356
consecutive	8356
cycles , which include the beginning phase , middle phase , ending phase , and middle swing , as well as the phase in stance	8377
cycles	8377
the beginning phase , middle phase , ending phase , and middle swing , as well as the phase in stance	8399
the beginning phase , middle phase , ending phase , and middle swing ,	8399
the beginning phase , middle phase ,	8399
the beginning phase	8399
middle phase	8420
phase , and middle swing ,	8441
phase	8441
middle swing	8452
the phase in stance	8477
the phase	8477
stance	8490
the normal rats and rats with full treatments -LRB- SCI+BT+TANES -RRB-	8508
the normal rats and rats	8508
full treatments -LRB- SCI+BT+TANES -RRB-	8538
full treatments	8538
SCI+BT+TANES	8555
stance with the support of the wall	8593
stance	8593
the support of the wall	8605
the support	8605
the wall	8620
their front limbs	8637
The horizontal line below each stick figure	8656
The horizontal line	8656
each stick figure	8682
the ground surface of the open field	8711
the ground surface	8711
the open field	8733
Fig. 3 -- Locomotor improvement .	8750
Fig. 3	8750
Locomotor improvement	8759
Representative photos saved from the video records	8782
Representative photos	8782
the video records	8815
the course of locomotor improvement	8838
the course	8838
locomotor improvement	8852
a typical rat in Group 4 -LRB- SCI+BT+TANES -RRB-	8879
a typical rat	8879
Group 4 -LRB- SCI+BT+TANES -RRB-	8896
Group 4	8896
SCI+BT+TANES	8905
combination treatments -LRB- 6 weeks after injury -RRB-	8927
combination treatments	8927
6 weeks after injury	8951
6 weeks	8951
injury	8965
the rat 's two hind limbs	8974
the rat 's	8974
the body weightmost of the time -LRB- arrowheads in A -RRB-	9017
the body weightmost	9017
the time -LRB- arrowheads in A -RRB-	9040
the time	9040
arrowheads in A	9050
arrowheads	9050
A	9064
Six weeks	9068
combination treatments	9084
the two hind limbs of the same rat	9108
the two hind limbs	9108
the same rat	9130
the body weight	9177
alternative movement of the two hind limbs	9198
alternative movement	9198
the two hind limbs	9222
the plantar	9248
arrows in B	9270
arrows	9270
B	9280
Typical posture of FL -- HL -LRB- front limbs , hind limbs -RRB- coordination is shown 14 weeks after combination treatments of the same rat -LRB- C -RRB- ; when compared with a normal rat -LRB- D -RRB- the postures of these two rats look quite similar .	9284
Typical posture of FL	9284
Typical posture	9284
FL	9303
HL -LRB- front limbs , hind limbs -RRB- coordination is shown 14 weeks after combination treatments of the same rat -LRB- C -RRB- ; when compared with a normal rat -LRB- D -RRB- the postures of these two rats look quite similar	9306
HL	9306
front limbs , hind limbs	9310
front limbs	9310
hind limbs	9323
coordination	9335
14 weeks	9357
combination treatments of the same rat	9372
combination treatments	9372
the same rat	9398
C	9412
a normal rat -LRB- D -RRB-	9435
a normal rat	9435
D	9449
the postures of these two rats	9452
the postures	9452
these two rats	9468
the right front limb -LRB- RF -RRB-	9519
the right front limb	9519
RF	9541
hind limb -LRB- LH -RRB-	9554
hind limb	9554
LH	9565
the left front limb -LRB- LF -RRB- and right hind limb -LRB- RH -RRB-	9590
the left front limb -LRB- LF -RRB-	9590
the left front limb	9590
LF	9611
right hind limb -LRB- RH -RRB-	9619
right hind limb	9619
RH	9636
Fig. 4 -- Longitudinal profile of injury epicenter .	9669
Fig. 4	9669
Longitudinal profile of injury epicenter	9678
Longitudinal profile	9678
injury epicenter	9702
Representative photomicrographs of longitudinal sections from a rat with basic treatments	9720
Representative photomicrographs	9720
longitudinal sections from a rat with basic treatments	9755
longitudinal sections	9755
a rat with basic treatments	9782
a rat	9782
basic treatments	9793
the lesion area	9815
tissue demarked by GFAP -LRB- arrows , A -RRB-	9842
tissue	9842
GFAP -LRB- arrows , A -RRB-	9861
GFAP	9861
arrows , A	9867
arrows	9867
A	9875
The lesion area	9879
p75NTR positive cells	9911
some tiny cysts -LRB- * , B -RRB-	9943
some tiny cysts	9943
*	9960
B	9963
Numerous axons -LRB- NF positive -RRB-	9967
Numerous axons	9967
NF	9983
the lesion area	10010
tissue -LRB- C -RRB-	10037
tissue	10037
C	10045
some of them	10049
some	10049
them	10057
the interfaces -LRB- broken lines -RRB- between spared tissue	10074
the interfaces -LRB- broken lines -RRB-	10074
the interfaces	10074
broken lines	10090
spared tissue	10112
lesion area in both rostral -LRB- D -RRB- and caudal -LRB- E -RRB-	10130
lesion area	10130
both rostral -LRB- D -RRB- and caudal -LRB- E -RRB-	10145
both rostral	10145
D	10159
caudal	10166
E	10174
the cord	10185
Scale bars : 0.5 mm -LRB- A , B , C -RRB- ; 0.2 mm -LRB- D , E -RRB- .	10195
Scale bars	10195
0.5 mm -LRB- A , B , C -RRB- ; 0.2 mm -LRB- D , E -RRB-	10207
0.5 mm -LRB- A , B , C -RRB-	10207
A , B , C	10214
0.2 mm -LRB- D , E -RRB-	10224
D , E	10231
D	10231
E	10234
Fig. 5 -- Tissue repair and glial scar disappearance .	10239
Fig. 5	10239
Tissue repair and glial scar disappearance	10248
Tissue repair	10248
glial scar disappearance	10266
A , B , C , and D	10292
B	10295
cross sections at the injury epicenter from different groups	10311
cross sections	10311
the injury epicenter from different groups	10329
the injury epicenter	10329
different groups	10355
the others in the same rows	10376
the others	10376
the same rows	10390
their local magnifications	10408
Panels in the left and middle columns	10450
Panels	10450
the left and middle columns	10460
the left	10460
middle columns	10473
H.E. staining	10492
those in the right column	10512
those	10512
the right column	10521
GFAP immunostaining	10542
tissue , lesion cavity ,	10570
tissue	10570
lesion cavity	10578
tissue	10606
the glial scars with sharp edge	10634
the glial scars	10634
sharp edge	10655
the arrows	10683
groups with basic treatments -LRB- rows C and D -RRB-	10698
groups	10698
basic treatments -LRB- rows C and D -RRB-	10710
basic treatments	10710
rows C and D	10728
the development of repaired tissue and integration of repaired tissue with spared tissue	10743
the development	10743
repaired tissue and integration of repaired tissue with spared tissue	10762
repaired tissue and integration	10762
repaired tissue with spared tissue	10797
repaired tissue	10797
spared tissue	10818
the lesion cavities and glial scars with sharp edge	10863
the lesion cavities	10863
glial scars with sharp edge	10887
glial scars	10887
sharp edge	10904
SCI : spinal cord injury ; BT : basic treatments ; TANES : tail nerve electrical stimulation ; ST : spared tissue ; DR : dorsal root ; VR : ventral root .	10938
SCI	10938
spinal cord injury ; BT : basic treatments ; TANES : tail nerve electrical stimulation ; ST : spared tissue	10943
spinal cord	10943
injury	10955
BT : basic treatments ; TANES : tail nerve electrical stimulation ; ST	10963
BT	10963
basic treatments ; TANES : tail nerve electrical stimulation	10967
basic treatments ; TANES	10967
basic treatments	10967
TANES	10985
tail nerve electrical stimulation	10992
tail nerve	10992
electrical stimulation	11003
ST	11027
tissue	11038
DR : dorsal root	11046
DR	11046
dorsal root	11050
VR : ventral root	11063
VR	11063
ventral root	11067
Scale bars : 0.5 mm -LRB- left column -RRB- , 50 μm -LRB- the rest -RRB- .	11081
Scale bars	11081
0.5 mm -LRB- left column -RRB- , 50 μm -LRB- the rest -RRB-	11093
0.5 mm	11093
left column	11100
50 μm -LRB- the rest -RRB-	11114
the rest	11121
Fig. 6 -- Quantitative analysis of tissue repair .	11133
Fig. 6	11133
Quantitative analysis of tissue repair	11142
Quantitative analysis	11142
tissue repair	11167
The percentages of spared tissue , repaired tissue and lesion cavity to the whole area of a cross section at the injury epicenter in each group	11182
The percentages	11182
spared tissue , repaired tissue and lesion cavity to the whole area of a cross section at the injury epicenter in each group	11201
spared tissue	11201
tissue and lesion cavity	11225
the whole area of a cross section	11253
the whole area	11253
a cross section	11271
the injury epicenter in each group	11290
the injury epicenter	11290
each group	11314
The development of repaired tissue	11336
The development	11336
repaired tissue	11355
the reduction of lesion cavities	11400
the reduction	11400
lesion cavities	11417
groups	11436
basic treatments -LRB- BT -RRB-	11448
basic treatments	11448
BT	11466
the control group	11490
p <	11510
p	11510
<	11511
0.05	11512
p <	11520
p	11520
<	11521
0.01	11522
Fig. 7 -- P0-positive myelination .	11529
Fig. 7	11529
P0-positive myelination	11538
Representative photomicrographs -LRB- A , H.E. staining ; B and C , P0-immunostaining -RRB- from a rat in Group 4 -LRB- SCI+BT+TANES -RRB-	11563
Representative photomicrographs -LRB- A , H.E. staining ; B and C , P0-immunostaining -RRB- from a rat in Group 4	11563
Representative photomicrographs -LRB- A , H.E. staining ; B and C , P0-immunostaining -RRB-	11563
Representative photomicrographs	11563
A , H.E. staining ; B and C , P0-immunostaining	11596
A	11596
H.E. staining ; B and C	11599
H.E. staining	11599
B and C	11614
P0-immunostaining	11623
a rat in Group 4	11647
a rat	11647
Group 4	11656
SCI+BT+TANES	11665
the P0-positive myelin sheaths	11689
repaired tissue and spared tissue -LRB- ST -RRB- , besides in the dorsal roots -LRB- DR -RRB- and ventral roots	11735
tissue	11744
tissue -LRB- ST -RRB- , besides in the dorsal roots -LRB- DR -RRB-	11762
tissue -LRB- ST -RRB-	11762
tissue	11762
ST	11770
the dorsal roots -LRB- DR -RRB-	11786
the dorsal roots	11786
DR	11804
The area of repaired tissue marked by asterisks -LRB- * -RRB-	11827
The area	11827
repaired tissue marked by asterisks -LRB- * -RRB-	11839
repaired tissue	11839
asterisks -LRB- * -RRB-	11865
asterisks	11865
numerous P0-positive myelin sheaths , which are magnified in C	11888
numerous P0-positive myelin sheaths	11888
C	11948
The P0-positive myelin sheaths	11951
small circles or dots	11992
brown	12017
some of them	12028
some	12028
them	12036
the arrowheads	12058
Most of nuclei stained by hematoxylin	12074
Most	12074
nuclei stained by hematoxylin	12082
nuclei	12082
hematoxylin	12100
Schwann cells	12126
Histogram -LRB- D -RRB-	12141
Histogram	12141
D	12151
the average numbers -LRB- Mean ± SEM -RRB- of P0-positive myelin sheaths in individual groups	12160
the average numbers -LRB- Mean ± SEM -RRB-	12160
the average numbers	12160
Mean ± SEM	12181
P0-positive myelin sheaths in individual groups	12194
P0-positive myelin sheaths	12194
individual groups	12224
Scale bars : 0.5 mm -LRB- A , B -RRB- , 50 μm -LRB- C -RRB- .	12243
Scale bars	12243
0.5 mm -LRB- A , B -RRB- , 50 μm -LRB- C -RRB-	12255
0.5 mm	12255
A , B	12262
A	12262
B	12265
50 μm -LRB- C -RRB-	12269
C	12276
The p values	12280
the histogram	12315
Fig. 8 -- Quantitative analysis of FB labeled neurons .	12331
Fig. 8	12331
Quantitative analysis of FB labeled neurons	12340
Quantitative analysis	12340
FB labeled neurons	12365
FB	12365
neurons	12376
Representative photomicrograph -LRB- A -RRB-	12385
Representative photomicrograph	12385
A	12417
the neurons	12426
the brain labeled by the retrograde tracer , fast blue , observed under the fluorescence microscope	12441
the brain	12441
the retrograde tracer , fast blue , observed under the fluorescence microscope	12462
the retrograde tracer	12462
the fluorescence microscope	12511
Some labeled neuronal cell bodies	12540
Some	12540
neuronal cell bodies	12553
the arrows	12589
Scale bar : 400 μm .	12601
Scale bar	12601
400 μm	12612
Histograms	12620
the number of FB-labeled neurons -LRB- Mean ± SEM -RRB-	12636
the number	12636
FB-labeled neurons -LRB- Mean ± SEM -RRB-	12650
FB-labeled neurons	12650
Mean ± SEM	12670
Mean	12670
± SEM	12674
motor cortex -LRB- B -RRB- , red nucleus -LRB- C -RRB- , lateral vestibular nucleus -LRB- D -RRB- , reticular formation -LRB- E -RRB- , raphe nucleus -LRB- F -RRB- , locus coeruleus -LRB- G -RRB- and the total number -LRB- H -RRB- in different groups -LRB- for details see Table 1 -RRB-	12685
motor cortex -LRB- B -RRB- , red nucleus -LRB- C -RRB- , lateral vestibular nucleus -LRB- D -RRB- , reticular formation -LRB- E -RRB- , raphe nucleus -LRB- F -RRB- , locus coeruleus -LRB- G -RRB- and the total number -LRB- H -RRB- in different groups	12685
motor cortex -LRB- B -RRB-	12685
motor cortex	12685
B	12699
red nucleus -LRB- C -RRB-	12703
red nucleus	12703
C	12716
lateral vestibular nucleus -LRB- D -RRB-	12720
lateral vestibular nucleus	12720
D	12748
reticular formation -LRB- E -RRB-	12752
reticular formation	12752
E	12773
raphe nucleus -LRB- F -RRB-	12777
raphe nucleus	12777
F	12792
locus coeruleus -LRB- G -RRB-	12796
locus coeruleus	12796
G	12813
the total number -LRB- H -RRB- in different groups	12820
the total number -LRB- H -RRB-	12820
the total number	12820
H	12838
different groups	12844
details	12866
Table 1	12878
The p values	12888
each individual histogram	12923
Fig. 9 -- Relationship between FB-labeled neurons and BBB scores .	12951
Fig. 9	12951
Relationship between FB-labeled neurons and BBB scores	12960
Relationship	12960
FB-labeled neurons and BBB scores	12981
FB-labeled neurons	12981
BBB scores	13004
The total numbers of FB-labeled neurons from each case with FB tracing	13016
The total numbers	13016
FB-labeled neurons from each case with FB tracing	13037
FB-labeled neurons	13037
each case with FB tracing	13061
each case	13061
FB tracing	13076
FB	13076
the BBB scores	13108
Linear regression analysis	13124
a significant positive correlation between FB-labeled neurons and BBB scores -LRB- r = 0.89 , n = 23 , p < 0.001 -RRB-	13157
a significant positive correlation	13157
FB-labeled neurons and BBB scores -LRB- r = 0.89 , n = 23 , p < 0.001 -RRB-	13200
FB-labeled neurons	13200
BBB scores -LRB- r = 0.89 , n = 23 , p < 0.001 -RRB-	13223
BBB scores	13223
r = 0.89 , n = 23 , p < 0.001	13235
r = 0.89	13235
r	13235
n = 23	13243
n	13243
23	13245
p < 0.001	13249
p <	13249
p	13249
0.001	13251
2.1	13260
Significant improvement of functional recovery	13265
Significant improvement	13265
functional recovery	13292
our previous observation -LRB- Zhang et al. , 2011a -RRB- , rats in two control groups , i.e. , Group 1 -LRB- SCI Control : 9.21 ± 0.22 to 9.38 ± 0.32 -RRB- and Group 3 -LRB- SCI+BT : 9.30 ± 0.33 to 9.60 ± 0.33 -RRB-	13323
our previous observation -LRB- Zhang et al. , 2011a -RRB-	13323
our previous observation	13323
Zhang	13349
et al. , 2011a	13355
et al.	13355
2011a	13363
rats in two control groups , i.e.	13371
rats	13371
two control groups	13379
Group 1 -LRB- SCI Control : 9.21 ± 0.22 to 9.38 ± 0.32 -RRB-	13405
Group 1	13405
SCI Control : 9.21 ± 0.22 to 9.38 ± 0.32	13414
SCI Control : 9.21 ± 0.22	13414
SCI Control	13414
9.21	13427
0.22	13432
9.38 ± 0.32	13440
Group 3 -LRB- SCI+BT : 9.30 ± 0.33 to 9.60 ± 0.33 -RRB-	13455
Group 3	13455
SCI+BT : 9.30 ± 0.33 to 9.60 ± 0.33	13464
SCI+BT : 9.30 ± 0.33	13464
SCI+BT	13464
9.30	13472
0.33	13477
9.60 ± 0.33	13485
their BBB scores	13509
the beginning -LRB- 6 weeks after contusion -RRB-	13548
the beginning	13548
6 weeks after contusion	13563
6 weeks	13563
contusion	13577
the end of the experiment -LRB- 22 weeks after injury or 16 weeks after secondary surgery -RRB-	13591
the end	13591
the experiment -LRB- 22 weeks after injury or 16 weeks after secondary surgery -RRB-	13602
the experiment	13602
22 weeks after injury or 16 weeks after secondary surgery	13618
22 weeks after injury	13618
22 weeks	13618
injury	13633
16 weeks after secondary surgery	13643
16 weeks	13643
secondary surgery	13658
The slight increase in their BBB scores	13678
The slight increase	13678
their BBB scores	13701
the limited endogenous ability of tissue repair and functional recovery -LRB- Beattie et al. , 1997 -RRB-	13736
the limited endogenous ability of tissue repair and functional recovery	13736
endogenous ability of tissue repair	13748
endogenous ability	13748
tissue repair	13770
Beattie	13809
et al. , 1997	13817
et al.	13817
1997	13825
there	13836
no significant difference between these two groups	13845
no significant difference	13845
these two groups	13879
that at the beginning and the end of the experiment of each group -LRB- Fig. 1 -RRB-	13917
that at the beginning	13917
that	13917
the beginning	13925
the end of the experiment of each group -LRB- Fig. 1 -RRB-	13943
the end	13943
the experiment of each group -LRB- Fig. 1 -RRB-	13954
the experiment	13954
each group -LRB- Fig. 1 -RRB-	13972
each group	13972
Fig. 1	13984
rats with TANES in both Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB- and Group 4 -LRB- SCI+BT+TANES : 9.33 ± 0.20 to 11.46 ± 0.47 -RRB-	14008
rats with TANES in both Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB- and Group 4	14008
rats	14008
TANES in both Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB- and Group 4	14018
TANES	14018
both Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB- and Group 4	14027
Group 2 -LRB- SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45 -RRB-	14032
Group 2	14032
SCI+TANES : 9.33 ± 0.22 to 10.67 ± 0.45	14041
SCI+TANES	14041
9.33 ± 0.22 to 10.67 ± 0.45	14052
9.33 ± 0.22	14052
9.33	14052
0.22	14057
10.67 ± 0.45	14065
Group 4	14081
SCI+BT+TANES : 9.33 ± 0.20 to 11.46 ± 0.47	14090
SCI+BT+TANES	14090
9.33 ± 0.20 to 11.46 ± 0.47	14104
9.33 ± 0.20	14104
9.33	14104
0.20	14109
11.46 ± 0.47	14117
improvement of functional recovery	14145
improvement	14145
functional recovery	14160
2 or 3 weeks	14180
physical therapy	14199
the end of the experiment	14228
the end	14228
the experiment	14239
most of the rats with TANES	14255
most	14255
the rats with TANES	14263
the rats	14263
TANES	14277
obvious improvement of functional recovery	14290
obvious improvement	14290
functional recovery	14313
The average BBB scores in Group 2 -LRB- p < 0.05 -RRB- and Group 4 -LRB- p < 0.01 -RRB-	14334
The average BBB scores	14334
Group 2 -LRB- p < 0.05 -RRB- and Group 4 -LRB- p < 0.01 -RRB-	14360
Group 2	14360
p < 0.05	14369
p	14369
< 0.05	14370
<	14370
0.05	14371
Group 4	14381
p < 0.01	14390
p	14390
< 0.01	14391
<	14391
0.01	14392
that of both Groups	14428
that	14428
both Groups	14436
1 and 3	14448
the end of the experiment	14459
the end	14459
the experiment	14470
addition	14489
comparison of BBB scores at the beginning and end of the experiments in these two groups	14499
comparison	14499
BBB scores at the beginning and end of the experiments in these two groups	14513
BBB scores	14513
the beginning and end of the experiments in these two groups	14527
the beginning and end	14527
the experiments in these two groups	14552
the experiments	14552
these two groups	14571
p < 0.01	14618
p	14618
< 0.01	14619
<	14619
0.01	14620
Fig. 1	14627
We	14636
the average BBB scores in Group 2 -LRB- SCI+TANES -RRB-	14655
the average BBB scores in Group 2	14655
the average BBB scores	14655
Group 2	14681
SCI+TANES	14690
increase with a significant difference	14701
increase	14701
a significant difference	14715
eight weeks	14740
treatments	14758
a plateau	14787
the end of the observation at 22 weeks	14803
the end	14803
the observation at 22 weeks	14814
the observation	14814
22 weeks	14833
contusion	14848
the average BBB scores in Group 4 -LRB- SCI+BT+TANES -RRB-	14868
the average BBB scores in Group 4	14868
the average BBB scores	14868
Group 4	14894
SCI+BT+TANES	14903
14 weeks	14939
the physical therapy treatment -LRB- Fig. 1 -RRB-	14954
the physical therapy treatment	14954
Fig. 1	14986
Qualitative kinematic analysis -LRB- Fig. 2 -RRB-	14995
Qualitative kinematic analysis	14995
Fig. 2	15027
normal rats	15050
the stepping cycle	15062
hind limb	15118
pattern	15145
The knee	15154
the ground	15183
The ankle	15195
the plantae	15227
the longitudinal axis of the body	15255
the longitudinal axis	15255
the body	15280
the swing phase	15293
the toes	15309
no contact with the ground surface	15323
no contact	15323
the ground surface	15339
addition	15362
the normal rat	15372
the support of front limbs	15405
the support	15405
front limbs	15420
the wall	15440
rats with chronic SCI -LRB- SCI Control -RRB-	15459
rats with chronic SCI	15459
rats	15459
chronic SCI	15469
SCI Control	15482
a certain degree of spontaneous recovery of function	15500
a certain degree	15500
spontaneous recovery of function	15520
spontaneous recovery	15520
function	15544
the knee always touches the ground and the ankle	15554
the knee	15554
touches the ground and the ankle	15570
touches	15570
the ground and the ankle	15578
the ground	15578
the ankle	15593
Rats with basic treatments -LRB- SCI+BT -RRB-	15639
Rats	15639
basic treatments -LRB- SCI+BT -RRB-	15649
basic treatments	15649
SCI+BT	15667
their ankles	15692
the body weight	15725
stance	15744
their knees	15756
the ground	15786
their hind limbs	15801
their body weight	15842
continuous stepping	15867
continuous	15867
the group of rats with full treatment -LRB- SCI+BT+TANES -RRB-	15891
the group	15891
rats with full treatment -LRB- SCI+BT+TANES -RRB-	15904
rats	15904
full treatment -LRB- SCI+BT+TANES -RRB-	15914
full treatment	15914
SCI+BT+TANES	15930
their hind limbs	15945
the body weight	15982
plantar stepping consistently	16003
plantar	16003
Their knees	16034
the ground	16062
The ankles	16074
normal rats	16143
they	16156
the front limbs holding the wall	16184
the front limbs	16184
the wall	16208
normal rats	16255
their hind limbs	16277
the ground	16306
the swing	16324
their behavior	16347
the normal rats	16381
addition	16401
the kinematic analysis	16411
rats without basic treatments but with TANES also	16448
rats	16448
basic treatments	16461
TANES	16487
significant improvement of locomotor pattern	16503
significant improvement	16503
locomotor pattern	16530
SCI control rats	16567
this group	16594
rats	16644
full treatments	16654
A typical ratwith significant functional recovery fromGroup 4 -LRB- SCI+BT+TANES -RRB-	16671
A typical ratwith significant functional recovery fromGroup 4	16671
A typical ratwith significant functional recovery fromGroup	16671
4	16731
SCI+BT+TANES	16734
Fig. 3	16761
the secondary surgery	16776
this ratwas unable	16799
her bodyweight	16829
her two hind limbs	16849
6 weeks after treatments , this rat	16892
6 weeks	16892
treatments , this rat	16906
treatments	16906
this rat	16918
prominent improvement of locomotor function in her two hind limbs	16934
prominent improvement	16934
locomotor function in her two hind limbs	16959
locomotor function	16959
her two hind limbs	16981
bodyweight supported stepping characterized by left -- right alternation and tail up	17017
bodyweight supported stepping characterized by left -- right alternation and tail	17017
bodyweight supported stepping characterized by left	17017
bodyweight	17017
right alternation and tail	17069
right alternation	17069
tail	17091
14 weeks after treatment	17103
14 weeks	17103
treatment	17118
this rat	17129
consistent coordination of front -- hind limb movement , when compared with a normal rat	17145
consistent coordination of front	17145
consistent coordination	17145
front	17172
hind limb movement , when compared with a normal rat	17178
hind limb movement	17178
a normal rat	17217
2.2	17231
Tissue repair and integration at the injury epicenter In order to understand the general situation of tissue repair and axonal regeneration at the injury epicenter , 3 rats were perfused 4 weeks after basic treatments and the spinal cords	17236
Tissue repair and integration	17236
the injury epicenter In order to understand the general situation of tissue repair and axonal regeneration at the injury epicenter , 3 rats were perfused 4 weeks after basic treatments and the spinal cords	17269
the injury epicenter	17269
the general situation of tissue repair and axonal regeneration	17313
the general situation	17313
tissue repair and axonal regeneration	17338
tissue repair	17338
axonal regeneration	17356
the injury epicenter	17379
3 rats	17401
4 weeks	17422
basic treatments and the spinal cords	17436
basic treatments	17436
the spinal cords	17457
longitudinal section	17493
The sections	17515
primary antibodies GFAP , p75NTR and neurofilament -LRB- NF -RRB-	17552
primary antibodies GFAP	17552
p75NTR and neurofilament -LRB- NF -RRB-	17577
p75NTR and neurofilament	17577
NF	17603
The results	17622
the spared tissue and lesion area	17647
the lesion area	17682
p75NTR positive cells	17714
they	17748
transplanted OECs or host Schwann cells , which contribute to the tissue repair	17764
transplanted OECs	17764
host Schwann cells , which contribute to the tissue repair	17785
host Schwann cells	17785
the tissue repair	17825
addition	17847
numerous axons	17857
the lesion area -LRB- regenerating -RRB-	17886
the lesion area	17886
the spared tissue	17931
many of them	17950
many	17950
them	17958
the boundary between the spared tissue and lesion area in both rostral and caudal ends of the cord	17990
the boundary	17990
the spared tissue and lesion area in both rostral and caudal ends of the cord	18011
the spared tissue and lesion area	18011
both rostral and caudal ends	18048
rostral	18053
caudal ends	18065
the cord	18080
these regenerating axons	18106
lesion area	18147
tissue -LRB- Fig. 4 -RRB-	18169
tissue	18169
Fig. 4	18177
Similar to our previous observation -LRB- Zhang et al. , 2011a -RRB- , in Group 1 -LRB- SCI Control -RRB- of the present study the repaired tissue -LRB- 43.36 ± 5.02 % -RRB- and the lesion cavity -LRB- 42.29 ± 6.00 % -RRB- were found lacking prominent change in size 22 weeks after injury ; the glial scar , which is located at the inner edge of the spared tissue and labeled with GFAP immunoreaction	18186
Similar to our previous observation -LRB- Zhang et al. , 2011a -RRB- , in Group 1 -LRB- SCI Control -RRB- of the present study the	18186
our previous observation -LRB- Zhang et al. , 2011a -RRB- , in Group 1 -LRB- SCI Control -RRB- of the present study	18197
our previous observation	18197
Zhang	18223
et al. , 2011a	18229
et al.	18229
2011a	18237
Group 1 -LRB- SCI Control -RRB- of the present study	18248
Group 1 -LRB- SCI Control -RRB-	18248
Group 1	18248
SCI Control	18257
the present study	18273
tissue -LRB- 43.36 ± 5.02 % -RRB- and the lesion cavity -LRB- 42.29 ± 6.00 % -RRB-	18304
tissue -LRB- 43.36 ± 5.02 % -RRB-	18304
tissue	18304
43.36 ± 5.02 %	18312
43.36	18312
5.02 %	18318
the lesion cavity -LRB- 42.29 ± 6.00 % -RRB-	18329
the lesion cavity	18329
42.29 ± 6.00 %	18348
42.29	18348
6.00 %	18354
prominent change	18380
size	18400
22 weeks	18405
injury ; the glial scar , which is located at the inner edge of the spared tissue	18420
injury	18420
the glial scar , which is located at the inner edge of the spared tissue	18428
the glial scar	18428
the inner edge of the spared tissue	18464
the inner edge	18464
the spared tissue	18482
GFAP immunoreaction	18517
Group 2 -LRB- SCI+TANES -RRB- , the repaired tissue was found slightly expanded -LRB- 60.31 ± 6.29 % -RRB- , but the lesion cavity -LRB- 28.00 ± 7.76 % -RRB- and glial scarwith	18564
Group 2 -LRB- SCI+TANES -RRB- , the repaired tissue was found slightly expanded -LRB- 60.31 ± 6.29 % -RRB-	18564
Group	18564
2 -LRB- SCI+TANES -RRB- , the repaired tissue was found slightly expanded -LRB- 60.31 ± 6.29 % -RRB-	18570
2 -LRB- SCI+TANES -RRB-	18570
the repaired tissue was found slightly expanded -LRB- 60.31 ± 6.29 %	18585
the	18585
tissue was found slightly expanded -LRB- 60.31	18598
tissue	18598
60.31	18634
6.29 %	18640
the lesion cavity -LRB- 28.00 ± 7.76 % -RRB- and glial scarwith	18652
the lesion cavity -LRB- 28.00 ± 7.76 % -RRB-	18652
the lesion cavity	18652
28.00 ± 7.76 %	18671
28.00	18671
7.76 %	18677
glial scarwith	18688
sharp edge	18703
In Group 3 -LRB- SCI+BT -RRB- and Group 4 -LRB- SCI+BT+TANES -RRB- , the expanded	18730
In Group 3 -LRB- SCI+BT -RRB- and Group 4 -LRB- SCI+BT+TANES -RRB- , the	18730
Group 3 -LRB- SCI+BT -RRB-	18733
Group 3	18733
SCI+BT	18742
Group 4 -LRB- SCI+BT+TANES -RRB- , the	18754
Group 4	18754
SCI+BT+TANES	18763
the	18778
tissue -LRB- 87.81 ± 0.99 % in Group 3 ; 87.62 ± 1.30 %	18800
tissue -LRB- 87.81 ± 0.99 % in Group 3	18800
tissue	18800
87.81 ± 0.99 % in Group 3	18808
87.81 ± 0.99 %	18808
87.81	18808
0.99 %	18814
Group 3	18823
87.62 ± 1.30 %	18832
87.62	18832
1.30 %	18838
Group 4 -RRB- almost completely occupied the damaged area , resulting in nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 % in Group 3 ; 1.97 ± 1.69 % in Group	18847
Group	18847
4 -RRB- almost completely occupied the damaged area , resulting in nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 % in Group 3 ; 1.97 ± 1.69 % in Group	18853
almost completely	18856
occupied the damaged area , resulting in nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 %	18874
the damaged area	18883
resulting in nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 %	18901
resulting	18901
nearly the disappearance of the lesion cavity -LRB- 2.42 ± 0.92 %	18914
nearly the disappearance	18914
the lesion cavity -LRB- 2.42 ± 0.92 %	18942
the lesion	18942
cavity -LRB- 2.42 ± 0.92 %	18953
cavity	18953
2.42 ± 0.92 %	18961
2.42	18961
0.92 %	18966
Group	18975
3 ; 1.97 ± 1.69 %	18981
3 ; 1.97	18981
1.69 %	18989
Group	18998
the integration of	19011
the integration	19011
tissue	19039
tissue ; simultaneously	19058
tissue	19058
almost no more glial scar with sharp edge	19082
almost no more glial scar	19082
sharp edge	19113
the spared tissues	19155
size	19204
the entire period of experiment -LRB- Figs. 5 and 6 -RRB-	19216
the entire period	19216
experiment -LRB- Figs. 5 and 6 -RRB-	19237
experiment	19237
Figs. 5 and 6	19249
Figs. 5	19249
6	19261
2.3	19265
Prominent enhancement of P0-positive myelination Monoclonal antibody P0	19270
Prominent enhancement	19270
P0-positive myelination Monoclonal antibody P0	19295
the myelin sheaths	19358
the characteristics of peripheral nerves	19382
the characteristics	19382
peripheral nerves	19405
the injury site ; as observed before these P0-positive myelin sheaths were found in the repaired tissue , lesion cavity	19426
the injury site	19426
these P0-positive myelin sheaths	19462
the repaired tissue , lesion cavity	19509
the repaired tissue	19509
lesion cavity	19530
tissue -LRB- Figs. 7A -- C -RRB-	19555
tissue	19555
Figs. 7A -- C	19563
Figs. 7A	19563
C	19572
They	19576
the host Schwann cells	19600
The myelinated fibers	19624
regenerating axons -LRB- in the repaired tissue -RRB-	19658
regenerating axons	19658
the repaired tissue	19681
axons -LRB- in the spared tissue -RRB-	19718
axons	19718
the spared tissue	19728
there	19760
axons	19797
The counts of P0-positive myelin sheaths in each group	19804
The counts	19804
P0-positive myelin sheaths in each group	19818
P0-positive myelin sheaths	19818
each group	19848
Mean ± SEM	19872
Group 1 -LRB- SCI control -RRB- : 1747 ± 255 -LRB- n = 5 -RRB- ; Group 2 -LRB- SCI+TANES -RRB- : 3561 ± 1301 -LRB- n = 4 -RRB- ; Group 3 -LRB- SCI+BT -RRB- : 3363 ± 485 -LRB- n = 4 -RRB- ; Group 4 -LRB- SCI+BT+TANES -RRB- : 5031 ± 1571 -LRB- n = 4 -RRB- .	19882
Group 1	19882
SCI control	19891
1747 ± 255 -LRB- n = 5 -RRB-	19905
1747 ±	19905
255 -LRB- n = 5 -RRB-	19910
255	19910
n	19915
5	19917
Group 2 -LRB- SCI+TANES -RRB-	19921
Group 2	19921
SCI+TANES	19930
3561 ± 1301 -LRB- n = 4 -RRB-	19942
3561 ± 1301	19942
3561	19942
1301	19947
n	19952
4	19954
Group 3 -LRB- SCI+BT -RRB-	19958
Group 3	19958
SCI+BT	19967
3363 ± 485 -LRB- n = 4 -RRB-	19976
3363 ±	19976
485 -LRB- n = 4 -RRB-	19981
485	19981
n	19986
4	19988
Group 4 -LRB- SCI+BT+TANES -RRB-	19992
Group 4	19992
SCI+BT+TANES	20001
5031 ± 1571 -LRB- n = 4 -RRB-	20016
5031 ± 1571	20016
5031	20016
1571	20021
n	20027
4	20029
Differences between Group 3 and Group 1 , and between Group 4 and Group 1	20033
Differences	20033
Group 3 and Group 1	20053
Group 3	20053
Group 1	20065
Group 4 and Group 1	20086
Group 4	20086
Group 1	20098
p < 0.05	20137
p	20137
< 0.05	20138
<	20138
0.05	20139
Fig. 7D	20146
2.4	20156
axonal regeneration of supraspinal neurons	20170
axonal regeneration	20170
supraspinal neurons	20193
the 4 standard groups	20221
one additional group -LRB- SCI 3w , 3 weeks after contusion -RRB- with sub-acute injury	20244
one additional group -LRB- SCI 3w , 3 weeks after contusion -RRB-	20244
one additional group	20244
SCI 3w , 3 weeks after contusion	20266
SCI 3w	20266
3 weeks after contusion	20274
3 weeks	20274
contusion	20288
sub-acute injury	20304
the tracing study to investigate the number of the supraspinal neurons , whose axons survived the contusion injury	20335
the number of the supraspinal neurons , whose axons survived the contusion injury	20368
the number	20368
the supraspinal neurons , whose axons survived the contusion injury	20382
the supraspinal neurons	20382
axons	20413
the contusion injury	20428
All numbers of FB-labeled neurons counted from motor cortex and brainstem nuclei including red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	20450
All numbers	20450
FB-labeled neurons counted from motor cortex and brainstem nuclei including red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	20465
FB-labeled neurons	20465
motor cortex and brainstem nuclei	20497
red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	20541
red nucleus	20541
lateral vestibular nucleus	20554
reticular formation	20582
raphe nucleus	20603
locus coeruleus	20622
Table 1	20653
Fig. 8	20674
the total number of labeled neurons	20694
the total number	20694
labeled neurons	20714
3 weeks -LRB- SCI 3w , n = 3 -RRB- and 22 weeks -LRB- SCI 22w , i.e. , Group 1 : SCI Control , n = 4 -RRB-	20761
3 weeks -LRB- SCI 3w , n = 3 -RRB-	20761
SCI 3w , n = 3	20770
SCI 3w	20770
n = 3	20778
n	20778
3	20780
22 weeks -LRB- SCI 22w , i.e. , Group 1 : SCI Control , n = 4 -RRB-	20787
SCI 22w , i.e. , Group 1 : SCI Control , n = 4	20797
SCI 22w , i.e.	20797
SCI 22w	20797
i.e.	20806
Group 1 : SCI Control	20812
Group 1	20812
SCI Control	20821
n = 4	20834
n	20834
4	20836
SCI	20845
Rats from either Group 2 -LRB- SCI+TANES , n = 4 -RRB- or Group 3 -LRB- SCI+BT , n = 4 -RRB-	20850
Rats from either Group 2 -LRB- SCI+TANES , n = 4 -RRB-	20850
Rats	20850
Group 2	20867
SCI+TANES , n = 4	20876
SCI+TANES	20876
n = 4	20887
n	20887
4	20889
Group 3 -LRB- SCI+BT , n = 4 -RRB-	20895
Group 3	20895
SCI+BT , n = 4	20904
SCI+BT	20904
n = 4	20912
n	20912
4	20914
slight changes in the number of labeled neurons	20922
slight changes	20922
the number of labeled neurons	20940
the number	20940
labeled neurons	20954
that from Group 1	20989
that	20989
Group 1	20999
SCI 22w	21008
the difference	21022
rats from Group 4 -LRB- SCI+BT + TANES , n = 5 -RRB-	21080
rats from Group 4	21080
rats	21080
Group 4	21090
SCI+BT + TANES	21099
SCI+BT	21099
TANES	21107
n = 5	21114
n	21114
= 5	21115
a significant increase in the number of labeled neurons	21124
a significant increase	21124
the number of labeled neurons	21150
the number	21150
labeled neurons	21164
the difference between Group 4 and any other group	21185
the difference	21185
Group 4 and any other group	21208
Group 4	21208
any other group	21220
p < 0.05	21266
p	21266
< 0.05	21267
<	21267
0.05	21268
addition	21278
neurons in Group 4	21298
neurons	21298
Group 4	21309
that of control group	21347
that	21347
control group	21355
most of nuclei	21372
most	21372
nuclei	21380
motor cortex and locus coeruleus	21399
motor cortex	21399
locus coeruleus	21416
the cortex	21437
the difference between Group 1 -LRB- SCI 22w -RRB- and Group 4 -LRB- SCI+BT+TANES -RRB-	21449
the difference	21449
Group 1 -LRB- SCI 22w -RRB- and Group 4 -LRB- SCI+BT+TANES -RRB-	21472
Group 1	21472
SCI 22w	21481
Group 4	21494
SCI+BT+TANES	21503
rats in Group 4	21545
rats	21545
Group 4	21553
10 times more labeled neurons than that in Group 1	21566
10 times more	21566
neurons	21588
that in Group 1	21601
that	21601
Group 1	21609
2.5	21618
Positive correlation between FB-labeled neurons and BBB scores	21623
Positive correlation	21623
FB-labeled neurons and BBB scores	21652
FB-labeled neurons	21652
BBB scores	21675
a potential relationship between BBB scores and regenerated axons from the cortex and nuclei of brainstem , numbers of FB-labeled neurons	21705
a potential relationship between BBB scores	21705
a potential relationship	21705
BBB scores	21738
regenerated axons from the cortex and nuclei of brainstem , numbers of FB-labeled neurons	21753
regenerated axons	21753
the cortex and nuclei of brainstem , numbers of FB-labeled neurons	21776
the cortex and nuclei	21776
brainstem , numbers of FB-labeled neurons	21801
brainstem	21801
numbers of FB-labeled neurons	21812
numbers	21812
FB-labeled neurons	21823
all 23 cases with FB tracing	21847
all 23 cases	21847
FB tracing	21865
FB	21865
the BBB open field locomotor scores	21897
Linear regression analysis	21934
a significant positive correlation between FB-labeled neurons and BBB scores -LRB- r = 0.89 , p < 0.001 ; Fig. 9 -RRB-	21968
a significant positive correlation between FB-labeled neurons	21968
a significant positive correlation	21968
FB-labeled neurons	22011
BBB scores -LRB- r = 0.89 , p < 0.001 ; Fig. 9 -RRB-	22034
BBB scores -LRB- r = 0.89 ,	22034
BBB scores	22034
r = 0.89	22046
r	22046
p	22054
0.001 ; Fig. 9	22056
0.001	22056
Fig. 9	22063
Discussion Here	22076
Discussion	22076
we	22092
significant recovery of locomotor function	22107
significant recovery	22107
locomotor function	22131
ratswith chronic spinal cord contusion injury	22168
the application of TANES	22217
the application	22217
TANES	22236
combinedwith scar ablation and LP	22243
combinedwith scar	22243
ablation and LP	22261
OEC transplantation into the injury site	22278
OEC transplantation	22278
the injury site	22303
Our results	22320
the temporary , active ability of walking induced by TANES	22350
the temporary , active ability	22350
TANES	22402
permanent ability to walk , namely functional recovery	22432
permanent ability to walk	22432
functional recovery	22466
The improvement of neurological outcome	22487
The improvement	22487
neurological outcome	22506
the spinal plasticity based on the tissue repair and axonal regeneration	22550
the spinal plasticity	22550
the tissue repair and axonal regeneration	22581
the tissue repair	22581
axonal regeneration	22603
We	22624
the activitydependent plasticity	22640
the activation of the CPG	22692
the activation	22692
the CPG	22710
the TANES	22723
the activation of the CPG	22756
the activation	22756
the CPG	22774
the lesion level of the spinal cord	22788
the lesion level	22788
the spinal cord	22808
It	22825
many treatment approaches including cell transplantation	22847
many treatment approaches	22847
cell transplantation	22883
functional recovery in acute or sub-acute SCImodels	22946
functional recovery	22946
acute or sub-acute SCImodels	22969
the same or similar approaches	22999
chronic models -LRB- Azanchi et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2011 -RRB-	23073
chronic models	23073
Azanchi et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2011	23089
Azanchi	23089
et al. , 2004 ; Houle and Tessler , 2003 ; Tetzlaff et al. , 2011	23097
et al. , 2004	23097
et al.	23097
2004	23105
Houle and Tessler , 2003	23111
Houle and Tessler	23111
2003	23130
Tetzlaff et al. , 2011	23136
Tetzlaff	23136
et al. , 2011	23145
et al.	23145
2011	23153
our results from this study	23170
our results	23170
this study	23187
the average BBB scores	23223
only about 2 points -LRB- from 9.33 to 11.46 -RRB- for the rats receiving full treatments	23252
only about 2 points	23252
9.33 to 11.46	23278
the rats receiving full treatments	23297
the rats	23297
full treatments	23316
fact	23336
it	23341
a remarkable recovery of locomotor function	23347
a remarkable recovery	23347
locomotor function	23372
The average BBB score of 9.33 means that most of rats -LRB- 7/12 -RRB- could not support their body weight during the dragging or stepping phases before treatment .	23392
The average BBB score	23392
9.33 means that most of rats -LRB- 7/12 -RRB- could not support their body weight during the dragging or stepping phases before treatment	23417
9.33 means	23417
most of rats -LRB- 7/12 -RRB-	23433
most	23433
rats -LRB- 7/12 -RRB-	23441
rats	23441
7/12	23447
their body weight	23471
the	23496
phases	23521
treatment	23535
combination treatments	23552
most of them -LRB- 9/12 -RRB-	23585
most of them	23585
most	23585
them	23593
9/12	23599
body-weight support	23670
some of them -LRB- 5/12 -RRB-	23695
some of them	23695
some	23695
them	23703
5/12	23709
occasional or frequent coordination of front limbs and hind limbs	23727
occasional or frequent coordination	23727
front limbs and hind limbs	23766
front limbs	23766
hind limbs	23782
Fig. 3	23810
the course of functional recovery of a representative case	23823
the course	23823
functional recovery of a representative case	23837
functional recovery	23837
a representative case	23860
the kinematic analysis of hind limb stepping cycle	23883
the kinematic analysis	23883
hind limb stepping cycle	23909
hind limb	23909
cycle	23928
the assessment in a certain degree	23948
the assessment	23948
a certain degree	23966
a critical progress	23995
ratswith chronic spinal injury in neurology	24019
ratswith chronic spinal injury	24019
neurology	24053
recent years	24067
spinal plasticity	24081
the physical activity is emerging as a major contributor to functional recovery -LRB- Behrman and Harkema , 2007 ; Chen et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006 -RRB-	24113
the physical activity	24113
a major contributor	24150
functional recovery -LRB- Behrman and Harkema , 2007 ; Chen et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006 -RRB-	24173
functional recovery	24173
Behrman and Harkema	24194
Behrman	24194
Harkema	24206
2007 ; Chen et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006	24215
2007	24215
Chen et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006	24221
Chen	24221
et al. , 2007 ; Dunlop , 2008 ; Jayaraman et al. , 2006	24226
et al. , 2007	24226
et al.	24226
2007	24234
Dunlop , 2008	24240
Dunlop	24240
2008	24248
Jayaraman et al. , 2006	24254
Jayaraman	24254
et al. , 2006	24264
et al.	24264
2006	24272
This	24279
the neurons ' ability to rearrange their anatomical and functional connectivity in response to environmental input	24294
the neurons '	24294
their anatomical and functional connectivity in response	24328
their anatomical and functional connectivity	24328
response	24376
environmental input	24388
The resulting effect	24409
a new or modified output demonstrated by recovering behaviors -LRB- Dunlop , 2008 -RRB-	24433
a new or modified output	24433
recovering behaviors -LRB- Dunlop , 2008 -RRB-	24474
recovering behaviors	24474
Dunlop	24496
2008	24504
the mechanisms mediating the locomotor recovery induced by intense repetitive training and locomotor training	24520
the mechanisms	24520
the locomotor recovery induced by intense repetitive training and locomotor training	24545
the locomotor recovery	24545
intense repetitive training and locomotor training	24579
activity-dependent plasticity likely	24656
activity-dependent plasticity	24656
a major role -LRB- Lynskey et al. , 2008 -RRB-	24699
a major role	24699
Lynskey	24713
et al. , 2008	24721
et al.	24721
2008	24729
Studies	24736
activity-dependent plasticity	24762
physical therapy benefits	24804
the functional recovery in various models -LRB- Becker et al. , 2003 ; Sadowsky and McDonald , 2009 ; Thickbroom and Mastaglia , 2009 -RRB-	24830
the functional recovery	24830
various models -LRB- Becker et al. , 2003 ; Sadowsky and McDonald , 2009 ; Thickbroom and Mastaglia , 2009 -RRB-	24857
various models	24857
Becker et al. , 2003 ; Sadowsky and McDonald , 2009 ; Thickbroom and Mastaglia , 2009	24873
Becker	24873
et al. , 2003 ; Sadowsky and McDonald , 2009 ; Thickbroom and Mastaglia , 2009	24880
et al. , 2003	24880
et al.	24880
2003	24888
Sadowsky and McDonald , 2009	24894
Sadowsky and McDonald	24894
2009	24917
Thickbroom and Mastaglia , 2009	24923
Thickbroom and Mastaglia	24923
2009	24949
many strategies to restore locomotion after thoracic SCI	24967
locomotion	24994
thoracic SCI	25011
approaches aimed at reactivating the lumbar neuronal network -LRB- CPG -RRB- and its plasticity -LRB- Boulenguez and Vinay , 2009 -RRB-	25040
approaches	25040
the lumbar neuronal network -LRB- CPG -RRB- and its plasticity -LRB- Boulenguez and Vinay , 2009 -RRB-	25073
the lumbar neuronal network -LRB- CPG -RRB-	25073
the lumbar neuronal network	25073
CPG	25102
its plasticity -LRB- Boulenguez and Vinay , 2009 -RRB-	25111
its plasticity	25111
Boulenguez and Vinay , 2009	25127
Boulenguez	25127
Vinay , 2009	25142
Vinay	25142
2009	25149
The CPG	25156
patterns of rhythmic activity for locomotion	25184
patterns	25184
rhythmic activity for locomotion	25196
rhythmic activity	25196
locomotion	25218
the absence of external feedback or supraspinal control -LRB- Deliagina et al. , 1999 ; Grillner , 1985 -RRB-	25237
the absence	25237
external feedback or supraspinal control -LRB- Deliagina et al. , 1999 ; Grillner , 1985 -RRB-	25252
external feedback or supraspinal control	25252
Deliagina	25294
et al. , 1999 ; Grillner , 1985	25304
et al.	25304
1999 ; Grillner	25312
1999	25312
Grillner	25318
1985	25328
our rat model	25338
the CPG located in L1-2 -LRB- Magnuson et al. , 1999 , 2005 -RRB-	25353
the CPG	25353
L1-2 -LRB- Magnuson et al. , 1999 , 2005 -RRB-	25372
L1-2	25372
Magnuson	25378
et al. , 1999 , 2005	25387
et al.	25387
1999	25395
2005	25401
contusion injury in T10	25431
contusion injury	25431
T10	25451
the TANES stimulation	25463
active body	25485
hind limbs	25525
right alternation	25546
This temporary , technique-induced walking ability	25572
the result from the activation of CPG , triggered by TANES -LRB- Zhang et al. , 2010 -RRB-	25643
the result	25643
the activation of CPG , triggered by TANES -LRB- Zhang et al. , 2010 -RRB-	25659
the activation	25659
CPG	25677
TANES -LRB- Zhang et al. , 2010 -RRB-	25695
TANES	25695
Zhang	25702
et al. , 2010	25708
et al.	25708
2010	25716
the present study	25726
significant functional recovery from chronic SCI following the application of TANES	25745
significant functional recovery	25745
chronic SCI	25782
the application of TANES	25804
the application	25804
TANES	25823
all likelihood	25836
the activity-dependent plasticity below the injury level promoted by TANES through the activation of CPG	25868
the activity-dependent plasticity	25868
the injury level promoted by TANES through the activation of CPG	25908
the injury level	25908
TANES	25937
the activation of CPG	25951
the activation	25951
CPG	25969
This	25974
the transformation of temporary , active ability	25991
the transformation	25991
temporary , active ability	26013
TANES	26058
permanent ability to walk , namely functional recovery	26069
permanent ability to walk	26069
functional recovery	26103
it	26128
Consistent with our previous studies , observation from this study	26165
Consistent	26165
our previous studies , observation from this study	26181
our previous studies	26181
observation from this study	26203
observation	26203
this study	26220
the basic treatments including scar ablation and LP/OEC transplantation	26258
the basic treatments	26258
scar ablation and LP/OEC transplantation	26289
scar ablation	26289
LP/OEC transplantation	26307
tissue repair and axonal regeneration -LRB- detected by NF staining and P0-positive myelination -RRB-	26338
tissue repair	26338
axonal regeneration -LRB- detected by NF staining and P0-positive myelination -RRB-	26356
axonal regeneration	26356
NF staining and P0-positive myelination	26389
NF staining	26389
P0-positive myelination	26405
only substantial tissue repair and profound axonal regeneration	26440
only substantial tissue repair	26440
profound axonal regeneration	26475
functional recovery	26533
chronic SCI models -LRB- Zhang et al. , 2011a -RRB-	26570
chronic SCI models	26570
Zhang	26590
et al. , 2011a	26596
et al.	26596
2011a	26604
The fast blue tracing data	26612
The fast blue	26612
data	26634
TANES	26657
supraspinal axonal regeneration	26675
the brain and brainstem , which may be related with the functional recovery	26710
the brain and brainstem	26710
the functional recovery	26761
It	26786
the TANES	26809
the CPG	26829
signals	26847
the brain and brainstem through the spared ascending fibers -LRB- Giuliani and Smith , 1987 -RRB- , which give rise to a strikingly extended activation of cortex and brainstem -LRB- Spenger et al. , 2000 -RRB- , resulting in supraspinal axon regeneration	26861
the brain and brainstem	26861
fibers -LRB- Giuliani and Smith , 1987 -RRB- , which give rise to a strikingly extended activation of cortex and brainstem -LRB- Spenger et al. , 2000 -RRB- , resulting in supraspinal axon regeneration	26914
fibers -LRB- Giuliani and Smith , 1987 -RRB-	26914
fibers	26914
Giuliani and Smith	26922
1987	26942
rise	26960
a strikingly extended activation of cortex and brainstem -LRB- Spenger et al. , 2000 -RRB-	26968
a strikingly extended activation	26968
cortex and brainstem -LRB- Spenger et al. , 2000 -RRB-	27004
cortex and brainstem	27004
Spenger	27026
et al. , 2000	27034
et al.	27034
2000	27042
supraspinal axon regeneration	27062
incomplete spinal cord injury	27096
the implementation of brain motor control	27127
the implementation	27127
brain motor control	27149
the profile of residual brain descending input and its integration with the functional neuronal circuits below the lesion -LRB- Dimitrijevic et al. , 2005 -RRB-	27180
the profile	27180
residual brain descending input and its integration with the functional neuronal circuits below the lesion -LRB- Dimitrijevic et al. , 2005 -RRB-	27195
residual brain descending input	27195
its integration with the functional neuronal circuits below the lesion -LRB- Dimitrijevic et al. , 2005 -RRB-	27231
its integration	27231
the functional neuronal circuits below the lesion -LRB- Dimitrijevic et al. , 2005 -RRB-	27252
the functional neuronal circuits	27252
the lesion -LRB- Dimitrijevic et al. , 2005 -RRB-	27291
the lesion	27291
Dimitrijevic	27303
et al. , 2005	27316
et al.	27316
2005	27324
These re-growing descending fibers , which are derived from the motor cortex and brainstem nuclei associated with hind limb locomotion ,	27331
These re-growing descending fibers	27331
the motor cortex and brainstem nuclei associated with hind limb locomotion	27390
the motor cortex	27390
brainstem nuclei associated with hind limb locomotion	27411
brainstem nuclei	27411
hind limb locomotion	27444
the establishment of a new structural relationship between the brain and spinal cord	27478
the establishment	27478
a new structural relationship between the brain and spinal cord	27499
a new structural relationship	27499
the brain and spinal cord	27537
the brain	27537
spinal cord	27551
The functions of this new structural relationship	27564
The functions	27564
this new structural relationship	27581
an alternative , but characteristic and consistent neurocontrol -LRB- Dimitrijevic , 1994 ; Dimitrijevic et al. , 1983 , 2005 -RRB-	27631
an alternative , but characteristic and consistent neurocontrol	27631
Dimitrijevic , 1994 ; Dimitrijevic et al. , 1983 , 2005	27695
Dimitrijevic	27695
1994 ; Dimitrijevic et al. , 1983	27709
1994	27709
Dimitrijevic et al. , 1983	27715
Dimitrijevic	27715
et al. , 1983	27728
et al.	27728
1983	27736
2005	27742
this study	27752
the differences in BBB scores between the groups	27763
the differences	27763
BBB scores between the groups	27782
BBB scores	27782
the groups	27801
the activity-dependent plasticity	27841
the level of injury site	27881
the level	27881
injury site	27894
Rats in injury	27907
Rats	27907
injury	27915
group -LRB- SCI Control -RRB-	27928
group	27928
SCI Control	27935
almost no change	27955
their BBB scores	27975
the last 16 weeks of observation , which further verifies that without intervention treatment , endogenous , spontaneous repair processes are restricted and slow following SCI -LRB- Beattie et al. , 1997 ; Belegu et al. , 2007 ; Brook et al. , 2000 ; Zhang et al. , 2011a -RRB-	27999
the last 16 weeks	27999
observation , which further verifies that without intervention treatment , endogenous , spontaneous repair processes are restricted and slow following SCI -LRB- Beattie et al. , 1997 ; Belegu et al. , 2007 ; Brook et al. , 2000 ; Zhang et al. , 2011a -RRB-	28020
observation	28020
intervention treatment	28069
endogenous , spontaneous repair processes	28093
SCI -LRB- Beattie et al. , 1997 ; Belegu et al. , 2007 ; Brook et al. , 2000 ; Zhang et al. , 2011a -RRB-	28168
SCI	28168
Beattie et al. , 1997 ; Belegu et al. , 2007 ; Brook et al. , 2000 ; Zhang et al. , 2011a	28173
Beattie	28173
et al. , 1997 ; Belegu et al. , 2007 ; Brook et al. , 2000 ; Zhang et al. , 2011a	28181
et al. , 1997	28181
et al.	28181
1997	28189
Belegu et al. , 2007	28195
Belegu	28195
et al. , 2007	28202
et al.	28202
2007	28210
Brook et al. , 2000	28216
Brook	28216
et al. , 2000	28222
et al.	28222
2000	28230
Zhang et al. , 2011a	28236
Zhang	28236
et al. , 2011a	28242
et al.	28242
2011a	28250
Rats that received scar ablation and LP/OEC transplantation -LRB- SCI+BT -RRB- also did not have their BBB scores	28258
Rats	28258
scar ablation and LP/OEC transplantation -LRB- SCI+BT -RRB-	28277
scar ablation and LP/OEC transplantation	28277
SCI+BT	28319
their BBB scores	28345
they	28393
significant tissue repair and an increase	28405
significant tissue repair	28405
an increase	28435
the number of P0-positive myelination	28450
the number	28450
P0-positive myelination	28464
This observation is consistent with our previous results and others ' study -LRB- Steward et al. , 2006 -RRB- , andmay share the same mechanism , i.e. , lacking effective activity-dependent plasticity induced by locomotor training , indicating that cellular transplantation therapies alone do not necessarily result in improvement of motor function in rats with chronic SCI .	28489
This observation	28489
This	28489
observation	28494
our previous results and others ' study -LRB- Steward et al. , 2006 -RRB- , andmay share the same mechanism	28525
our previous results	28525
others ' study -LRB- Steward et al. , 2006 -RRB-	28550
others ' study	28550
others '	28550
Steward	28565
et al. , 2006	28573
et al.	28573
2006	28581
andmay share the same mechanism	28588
andmay share	28588
the same mechanism	28601
effective activity-dependent plasticity induced by locomotor training	28635
effective activity-dependent plasticity	28635
locomotor training	28686
cellular transplantation therapies	28722
improvement of motor function	28792
improvement	28792
motor function	28807
rats with chronic SCI	28825
rats	28825
chronic SCI	28835
the injured rats with both basic treatments and TANES -LRB- SCI+BT + TANES -RRB-	28857
the injured rats	28857
both basic treatments and TANES -LRB- SCI+BT + TANES -RRB-	28879
both basic treatments and TANES	28879
SCI+BT + TANES	28912
SCI+BT	28912
TANES	28920
their BBB scores	28932
increasing and improvement of functional recovery	28963
increasing and improvement	28963
functional recovery	28993
this	29034
the activity-dependent plasticity promoted by TANES through the activation of CPG -LRB- Zhang et al. , 2010 -RRB-	29060
the activity-dependent plasticity	29060
TANES	29106
the activation of CPG -LRB- Zhang et al. , 2010 -RRB-	29120
the activation	29120
CPG -LRB- Zhang et al. , 2010 -RRB-	29138
CPG	29138
Zhang	29143
et al. , 2010	29149
et al.	29149
2010	29157
rats that received only TANES but no basic treatments -LRB- SCI+TANES -RRB-	29179
rats	29179
only TANES but no basic treatments -LRB- SCI+TANES -RRB-	29198
only TANES	29198
no basic treatments -LRB- SCI+TANES -RRB-	29213
no basic treatments	29213
SCI+TANES	29234
an obvious increase in their BBB scores	29254
an obvious increase	29254
their BBB scores	29277
their tissue repair , P0-positivemyelination and FB tracing	29304
their tissue repair	29304
P0-positivemyelination and FB tracing	29325
P0-positivemyelination and FB	29325
the control animals	29400
The functional improvement in this conditionmay	29421
The functional improvement	29421
this conditionmay	29451
the activity-dependent plasticity induced by TANES , because this intrinsic plasticity can allowfunctional recovery in the absence of significant regeneration -LRB- Edgerton et al. , 2004 ; Harel and Strittmatter , 2006 -RRB-	29483
the activity-dependent plasticity	29483
TANES	29528
this intrinsic plasticity	29543
allowfunctional recovery	29573
the absence of significant regeneration -LRB- Edgerton et al. , 2004 ; Harel and Strittmatter , 2006 -RRB-	29601
the absence	29601
significant regeneration -LRB- Edgerton et al. , 2004 ; Harel and Strittmatter , 2006 -RRB-	29616
significant regeneration	29616
Edgerton	29642
et al. , 2004 ; Harel and Strittmatter , 2006	29651
et al.	29651
2004 ; Harel and Strittmatter	29659
2004	29659
Harel and Strittmatter	29665
2006	29689
steady tissue repair or axonal regeneration as an anatomic foundation	29718
steady tissue repair or axonal regeneration	29718
an anatomic foundation	29765
the role of physical therapy	29789
the role	29789
physical therapy	29801
functional recovery	29849
rats with chronic SCI	29872
rats	29872
chronic SCI	29882
This inference	29895
some cases in a recent clinical trial -LRB- Schalow , 2008 -RRB-	29929
some cases	29929
a recent clinical trial -LRB- Schalow , 2008 -RRB-	29943
a recent clinical trial	29943
Schalow	29968
2008	29977
summary	29987
TANES	29996
functional recovery in rats with chronically contused spinal cord	30025
functional recovery	30025
rats with chronically contused spinal cord	30048
rats	30048
chronically contused spinal cord	30058
scar ablation and LP/OEC transplantation , probably attributed to the activity-dependent plasticity below the injury level promoted by the activation of CPG	30097
scar ablation and LP/OEC transplantation	30097
the activity-dependent plasticity	30162
the injury level promoted by the activation of CPG	30202
the injury level	30202
the activation of CPG	30231
the activation	30231
CPG	30249
moderate functional recovery	30263
the TANES in the absence of steady tissue repair and axonal regeneration	30311
the TANES	30311
the absence of steady tissue repair and axonal regeneration	30324
the absence	30324
steady tissue repair and axonal regeneration	30339
steady tissue repair	30339
axonal regeneration	30364
tissue repair and axonal regeneration	30385
tissue repair	30385
axonal regeneration	30403
the anatomical foundation of effective plasticity , which renders the injured rat permanent ability to walk	30441
the anatomical foundation	30441
effective plasticity , which renders the injured rat permanent ability to walk	30470
effective plasticity	30470
the injured rat permanent ability	30506
TANES	30549
axonal regeneration	30564
the cortex and brainstem , which may be related with the improvement of motor behavior	30587
the cortex and brainstem	30587
the improvement of motor behavior	30639
the improvement	30639
motor behavior	30658
Our results	30674
light	30697
the study of chronic SCI	30706
the study	30706
chronic SCI	30719
TANES	30732
considerable potential	30747
improvement	30784
functional outcomes in patients with chronic SCI	30799
functional outcomes	30799
patients with chronic SCI	30822
patients	30822
chronic SCI	30836
Experimental procedures 4.1 .	30853
Experimental procedures	30853
4.1	30877
Animal and grouping Long -- Evans rats -LRB- female , body weight 200 -- 220 g -RRB- were used for this study .	30882
Animal and grouping Long	30882
Animal	30882
grouping Long	30893
Evans rats -LRB- female , body weight 200 -- 220 g -RRB-	30907
Evans rats	30907
female , body weight 200 -- 220 g	30919
female	30919
body weight 200 -- 220 g	30927
body weight 200	30927
body weight	30927
200	30939
220 g	30943
this study	30964
The rats	30976
plastic cages	31007
standard conditions with free access	31027
standard conditions	31027
free access	31052
drinking water and standard food	31067
drinking water	31067
standard food	31086
All rats	31101
contusion injury	31119
4 groups	31167
Rats in Group 1 -LRB- SCI Control , n = 12 -RRB-	31177
Rats in Group 1	31177
Rats	31177
Group 1	31185
SCI Control , n = 12	31194
SCI Control	31194
n = 12	31207
n	31207
12	31209
the injury	31227
alone control in order	31238
alone control	31238
order	31255
a baseline of the locomotor behavior	31268
a baseline	31268
the locomotor behavior	31282
Rats in Group 2 -LRB- SCI+TANES , n = 9 -RRB-	31306
Rats in Group 2	31306
Rats	31306
Group 2	31314
SCI+TANES , n = 9	31323
SCI+TANES	31323
n = 9	31334
n	31334
9	31336
TANES starting at 7 weeks after contusion injury until 22 weeks	31348
TANES	31348
7 weeks	31366
contusion injury	31380
22 weeks	31403
Rats in Group 3 -LRB- SCI+BT , n = 10 -RRB-	31413
Rats in Group 3	31413
Rats	31413
Group 3	31421
SCI+BT , n = 10	31430
SCI+BT	31430
n = 10	31438
n	31438
10	31440
basic treatments -LRB- BT -RRB- 6 weeks	31453
basic treatments -LRB- BT -RRB-	31453
basic treatments	31453
BT	31471
6 weeks	31475
contusion injury	31489
the basic treatments	31507
scar ablation and LP/OEC transplantation as in our previous study	31536
scar ablation and LP/OEC transplantation	31536
our previous study	31583
Rats in Group 4 -LRB- SCI+BT+TANES , n = 12 -RRB-	31603
Rats in Group 4	31603
Rats	31603
Group 4	31611
SCI+BT+TANES , n = 12	31620
SCI+BT+TANES	31620
n = 12	31634
n	31634
12	31636
basic treatments	31649
TANES	31678
Twenty two weeks	31685
contusion injury or 16 weeks after transplantation	31708
contusion injury	31708
16 weeks after transplantation	31728
16 weeks	31728
transplantation	31743
all rats	31760
sodium pentobarbital -LRB- 60mg/kg , i.p. -RRB-	31799
sodium pentobarbital	31799
60mg/kg , i.p.	31821
60mg/kg	31821
phosphate-buffered 4 % paraformaldehyde	31869
the neurons	31918
the cortex and brainstem , whose axons survived the contusion or regenerated behind the injury site	31933
the cortex and brainstem	31933
axons	31965
the contusion	31980
the injury site	32016
4 to 5 rats from each group	32033
4 to 5 rats	32033
each group	32050
fast blue	32099
the end of the experiment	32112
the end	32112
the experiment	32123
addition	32142
3 additional ratswere	32152
the same purpose as subacute injury control	32183
the same purpose	32183
subacute injury control	32203
SCI 3w ; 3 weeks	32228
SCI 3w	32228
3 weeks	32236
contusion	32250
All rats with neurotracing	32262
All rats	32262
neurotracing	32276
one more	32317
week	32326
All surgical and physical therapy procedures , including interventions , pre - and post-surgery care and electrical stimulation ,	32332
All surgical and physical therapy procedures	32332
interventions , pre - and post-surgery care and electrical stimulation	32388
interventions	32388
pre - and post-surgery care and electrical stimulation	32403
pre - and post-surgery care	32403
electrical stimulation	32434
the Institutional Animal Use and Care Committee of CARE Research , Inc	32475
the Institutional Animal Use and Care Committee	32475
CARE Research , Inc	32526
CARE Research	32526
Inc	32541
the Guide for the Care and Use of Laboratory Animals -LRB- 1996 -RRB-	32569
the Guide for the Care and Use of Laboratory Animals	32569
the Care	32583
Laboratory	32603
1996	32623
4.2	32630
Preparation of LP and OECs for transplantation LP used for transplantation	32635
Preparation	32635
LP and OECs	32650
transplantation LP used for transplantation	32666
transplantation LP	32666
transplantation	32694
the protocol as described previously -LRB- Zhang et al. , 2011a -RRB-	32733
the protocol	32733
Zhang	32771
et al. , 2011a	32777
et al.	32777
2011a	32785
the olfactory mucosa	32802
the nasal septum of a donor Long -- Evans rat	32841
the nasal septum	32841
a donor Long -- Evans rat	32861
Evans	32874
Dispase II -LRB- Roche -RRB- for 35 -- 40 min at 37 °C	32902
Dispase II -LRB- Roche -RRB- for 35	32902
Dispase II -LRB- Roche -RRB-	32902
Dispase II	32902
Roche	32914
35	32925
40 min at 37 °C	32928
40 min	32928
37 °C	32938
The olfactory epithelium	32945
forceps thereby exposing the LP	33000
forceps	33000
the LP	33025
transplantation	33037
the LP	33054
1.0 × 1.0 mm squares	33074
L-15 on ice	33104
L-15	33104
ice	33112
transplant	33122
OECs	33134
the LP of adult Long	33158
the LP	33158
adult Long	33168
Evans rats according to the basic protocols	33179
Evans rats	33179
the basic protocols	33203
elsewhere -LRB- Au and Roskams , 2002 -RRB-	33232
elsewhere	33232
Au and Roskams	33243
2002	33259
isolated LP	33275
37 °C in collagenase	33303
37 °C	33303
collagenase	33312
30 min followed by incubation in SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution for 15 min	33328
30 min	33328
incubation	33347
SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution for 15 min	33361
SD -LRB- Soybean Trypsin inhibitor/DNase -RRB- solution	33361
SD -LRB- Soybean Trypsin inhibitor/DNase -RRB-	33361
SD	33361
Soybean Trypsin inhibitor/DNase	33365
15 min	33411
The tissue	33419
3 times	33459
22	33475
25 gauge	33482
growth medium	33504
400 × g	33527
growth	33548
medium on a matrigel-coated T25 flask	33555
medium	33555
a matrigel-coated T25 flask	33565
24 h	33612
non-adherent cells	33618
fresh media	33654
the culture	33682
Cultures	33695
an additional 4	33719
7 days until nearly confluent	33735
7 days	33735
contaminating fibroblasts	33781
the cultures -LRB- Noble and Murray , 1984 -RRB-	33812
the cultures	33812
Noble and Murray	33826
1984	33844
OECs -LRB- among which may contain some contaminated Schwann cells -RRB-	33851
OECs	33851
some contaminated Schwann cells	33881
some	33881
Schwann cells	33899
liquid nitrogen in working aliquots	33943
liquid nitrogen	33943
working aliquots	33962
4.3	33980
Spinal cord injury and post-op care Contusion injury to the spinal cord	33985
Spinal cord injury	33985
post-op care Contusion injury to the spinal cord	34008
post-op care Contusion injury	34008
the spinal cord	34041
the NYU -LRB- New York University -RRB- impactor device , as described before -LRB- Zhang et al. , 2000 -RRB-	34079
the NYU -LRB- New York University -RRB- impactor device	34079
New York University	34088
Zhang et al. , 2000	34147
Zhang	34147
et al.	34153
2000	34161
deep anesthesia with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	34182
deep anesthesia	34182
sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	34203
sodium pentobarbital	34203
50 mg/kg , i.p.	34225
50 mg/kg	34225
the vertebral column	34242
the spinous process	34295
vertebra	34318
thoracic -LRB- T -RRB- level T7 and T10	34327
thoracic -LRB- T -RRB-	34327
level T7 and T10	34340
a dorsal laminectomy	34364
T8 and T9	34402
the spinal cord segments T9 and T10	34413
the dura mater intact	34467
the dura mater	34467
The 10 g impact rod	34490
spinal cord segment T10	34530
a height of 25 mm	34559
a height	34559
25 mm	34571
the exposed part of the cord	34578
the exposed part	34578
the cord	34598
a piece of adipose tissue	34624
a piece	34624
adipose tissue	34635
The contusion injury	34651
hind limb	34684
locomotor deficits as described previously -LRB- Constantini and Young , 1994 -RRB-	34694
locomotor deficits as described previously	34694
locomotor deficits	34694
Constantini and Young	34738
1994	34761
Analgesia buprenorphine -LRB- 0.02 mg/kg , sc , b.i.d. -RRB-	34768
Analgesia buprenorphine	34768
0.02 mg/kg , sc , b.i.d.	34793
0.02 mg/kg	34793
sc	34804
b.i.d.	34808
the pain for the first two days	34839
the pain	34839
the first two days	34852
injury/surgery	34877
Antibiotic cephazolin -LRB- 20mg/kg , sc , b.i.d. -RRB-	34893
Antibiotic cephazolin	34893
20mg/kg , sc , b.i.d.	34916
possible infection	34965
the wound and bladder for one	34987
the wound and bladder	34987
one	35013
week	35017
Urinary bladders	35023
hand	35066
twice a day	35071
adequate spontaneous voiding returned	35089
adequate spontaneous voiding	35089
attention	35128
the body skin	35155
addition	35177
saline solution -LRB- 0.9 % , 10 ml , sc -RRB-	35187
saline solution	35187
0.9 %	35204
10 ml	35210
sc	35217
one	35240
week	35244
dehydration	35260
The body weight of animals	35273
The body weight	35273
animals	35292
the first two weeks	35325
surgery and once a week	35351
surgery	35351
once a week	35363
4.4	35386
Scar ablation with photochemistry Six weeks after contusion injury the scar ablation	35391
Scar ablation	35391
photochemistry Six weeks after contusion injury the scar ablation	35410
photochemistry	35410
Six weeks	35425
contusion injury	35441
the scar ablation	35458
the injury epicenter	35493
the transplantation , as described before -LRB- Zhang et al. , 2007a -RRB-	35526
the transplantation	35526
Zhang et al. , 2007a	35568
Zhang	35568
et al.	35574
2007a	35582
deep anesthesia with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	35605
deep anesthesia	35605
sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	35626
sodium pentobarbital	35626
50 mg/kg , i.p.	35648
50 mg/kg	35648
the wound	35665
the injury site of the spinal cord	35692
the injury site	35692
the spinal cord	35711
the dura	35755
One -LRB- 1.0 -RRB- μl of 2 %	35765
One -LRB- 1.0 -RRB- μl	35765
One -LRB- 1.0 -RRB-	35765
One	35765
1.0	35770
2 %	35781
Bengal in saline	35789
Bengal	35789
saline	35799
the lesion cavity	35831
a glass pipette connected to a microinjector , which was fixed in a stereotaxic instrument	35857
a glass pipette	35857
a microinjector , which was fixed in a stereotaxic instrument	35886
a microinjector	35886
a stereotaxic instrument	35922
The	35948
Bengal within the cavity	35957
Bengal	35957
the cavity	35971
5 min	36009
injection	36020
the injury site	36031
5 min	36072
the full spectrum light of a halogen bulb -LRB- 150 W , 7 cm distance -RRB-	36083
the full spectrum light	36083
a halogen bulb -LRB- 150 W , 7 cm distance -RRB-	36110
a halogen bulb	36110
150 W	36126
7 cm distance	36133
unnecessary damage	36160
the heating source	36182
the halogen light	36206
the exposed part of spinal cord	36225
the exposed part	36225
spinal cord	36245
room temperature saline solution	36273
fresh change	36311
every 30 s	36324
the illumination	36342
4.5	36360
Transplantation of OECs and LP Transplantation	36365
Transplantation	36365
OECs and LP Transplantation	36384
photochemical scar ablation as described previously -LRB- Zhang et al. , 2011a -RRB-	36444
photochemical scar ablation	36444
Zhang	36497
et al. , 2011a	36503
et al.	36503
2011a	36511
the surgical microscopy	36534
1.0 μl of OEC suspension -LRB- 6 × 106 cells -RRB-	36559
1.0 μl	36559
OEC suspension -LRB- 6 × 106 cells -RRB-	36569
OEC suspension	36569
6 × 106 cells	36585
6 ×	36585
106 cells	36587
the lesion cavity	36616
a 31 gauge needle connecting to a Hamilton syringe prior LP delivery	36642
a 31 gauge needle	36642
a Hamilton syringe	36674
LP delivery	36699
Ten minutes later	36712
the dura	36731
a 1.0 mm scission on the median line of the spinal cord at the injury epicenter	36771
a 1.0 mm scission	36771
the median line of the spinal cord at the injury epicenter	36792
the median line	36792
the spinal cord at the injury epicenter	36811
the spinal cord	36811
the injury epicenter	36830
an 11 blade	36865
the lesion cavity	36887
Two pieces of LP -LRB- 1.0 × 1.0 mm -RRB-	36906
Two pieces of LP	36906
Two pieces	36906
LP	36920
1.0 × 1.0 mm	36924
1.0 × 1.0	36924
1.0	36924
1.0	36928
mm	36932
the lesion cavity	36966
the dura	36996
a 10-0 Novafil nylon suture -LRB- Ethicon , Somerville , NJ , USA -RRB-	37033
a 10-0 Novafil nylon suture	37033
Ethicon	37062
Somerville	37071
NJ , USA	37083
whichwas	37093
the dura and ready to tighten up immediately after LP delivery	37109
the dura	37109
ready to tighten up immediately after LP delivery	37122
LP	37160
the muscle and skin	37178
proper sutures	37215
4.6	37245
Tail nerve electrical stimulation The electrical stimulation	37250
Tail nerve electrical stimulation	37250
Tail nerve	37250
electrical stimulation	37261
The electrical stimulation	37284
one week	37319
basic treatments or 7 weeks	37334
basic treatments	37334
7 weeks	37354
contusion injury	37368
a physical therapy instrument -LRB- Type J18A1 computer control middle frequency instrument , made by Quan-Ri-Kang Company in China ; it has been demonstrated no risk and no side effect in the application in clinic and home -RRB-	37394
a physical therapy instrument	37394
Type J18A1 computer control middle frequency instrument , made by Quan-Ri-Kang Company in China ; it has been demonstrated no risk and no side effect in the application in clinic and home	37425
Type J18A1 computer control middle frequency instrument , made by Quan-Ri-Kang Company in China ; it has been demonstrated no risk	37425
Type J18A1 computer control middle frequency instrument , made by Quan-Ri-Kang Company in China	37425
Type J18A1 computer control middle frequency instrument	37425
Type J18A1 computer control	37425
middle frequency instrument	37453
Quan-Ri-Kang Company in China	37490
Quan-Ri-Kang Company	37490
China	37514
it	37521
no risk	37546
no side effect in the application in clinic and home	37558
no side effect	37558
the application in clinic and home	37576
the application	37576
clinic and home	37595
The instrument	37613
a middle frequency carrier wave of 2.5 -- 8 kHz and low adjustable frequency 0 -- 150 Hz with a maximal output current 100mA	37632
a middle frequency carrier wave of 2.5	37632
a middle frequency carrier wave	37632
2.5	37667
8 kHz and low adjustable frequency 0	37671
8 kHz	37671
low adjustable frequency 0	37681
150 Hz with a maximal output current 100mA	37708
150 Hz	37708
a maximal output current 100mA	37720
The strength of stimulation	37752
The strength	37752
stimulation	37768
the response of rats to the stimulation , usually between 10 and 40mA at a frequency of 4 kHz	37809
the response	37809
rats to the stimulation , usually between 10 and 40mA at a frequency of 4 kHz	37825
rats to the stimulation , usually between 10	37825
rats	37825
the stimulation	37833
10	37866
40mA at a frequency of 4 kHz	37873
40mA	37873
a frequency of 4 kHz	37881
a frequency	37881
4 kHz	37896
TANES	37903
Zhang et al. , 2010	37948
Zhang	37948
et al.	37954
2010	37962
anesthesia	37986
the rat	37997
an open field -LRB- plastic swimming pool with a diameter of 4 ft -RRB-	38016
an open field	38016
plastic swimming pool with a diameter of 4 ft	38031
plastic swimming pool	38031
a diameter of 4 ft	38058
a diameter	38058
4 ft	38072
The rat 's tail	38079
The rat 's	38079
the instrument with two electrodes	38116
the instrument	38116
two electrodes	38136
the stimulation current	38157
the rat 's tail	38189
the rat 's	38189
the two hind limbs	38205
tomove	38232
The rats	38270
step	38302
the open field	38335
the stimulation	38357
possiblemuscle fatigue	38385
the over movement of the leg muscle	38415
the over movement	38415
the leg muscle	38436
the movement of the hind limb	38452
the movement	38452
the hind limb	38468
40 -- 60 steps per minute	38497
40	38497
60 steps per minute	38500
60 steps	38500
minute	38513
the stimulating strength	38534
The electrical stimulation	38560
20 min per session , 5 sessions a week ,	38594
20 min	38594
session , 5 sessions a week ,	38605
session	38605
5 sessions a week	38614
5 sessions	38614
a week	38625
a total of 15 weeks	38637
a total	38637
15 weeks	38648
4.7	38658
Evaluation of hind limb locomotor function The neurological outcome	38663
Evaluation	38663
hind limb locomotor function The neurological outcome	38677
hind limb locomotor function	38677
The neurological outcome	38706
three independent people using thewell-knownopen field locomotion rating scale , BBB scale -LRB- Basso et al. , 1995 , 1996 -RRB-	38748
three independent people	38748
thewell-knownopen field locomotion rating scale , BBB scale -LRB- Basso et al. , 1995 , 1996 -RRB-	38779
thewell-knownopen field locomotion rating scale	38779
BBB scale	38828
Basso	38839
et al. , 1995 , 1996	38845
et al.	38845
1995	38853
1996	38859
contusion injury	38872
the BBB scores	38890
1 day , 3 days , 7 days post-injury and once aweek	38920
1 day	38920
3 days	38927
7 days post-injury	38935
once aweek	38958
addition	38983
a video record -LRB- 1 to 2minute long each time -RRB-	38993
a video record	38993
1 to 2minute long each time	39009
1	39009
2minute	39014
each time	39027
weekly for each rat	39047
weekly	39047
each rat	39058
The moving patterns of the hind limbswere	39068
The moving patterns	39068
the hind limbswere	39091
carefullywith	39119
the help of slowmotion video records	39133
the help	39133
slowmotion video records	39145
The final BBB score for each time point	39171
The final BBB score	39171
each time point	39195
the BBB paper record	39239
the results of the video record review	39265
the results	39265
the video record review	39280
detail , the individual movements of hind limb	39321
detail	39321
the individual movements of hind limb	39329
the individual movements	39329
hind limb	39357
the locomotion in an open field	39374
the locomotion	39374
an open field	39392
kinematic analysis	39407
the videotaped recordings using the modified Peak Performance Movement Analysis System -LRB- Coumans et al. , 2001 ; Muir and Webb , 2000 -RRB-	39449
the videotaped recordings	39449
the modified Peak Performance Movement Analysis System -LRB- Coumans et al. , 2001 ; Muir and Webb , 2000 -RRB-	39481
the modified Peak Performance Movement Analysis System	39481
Coumans	39537
et al. , 2001 ; Muir and Webb , 2000	39545
et al.	39545
2001 ; Muir and Webb	39553
2001	39553
Muir and Webb	39559
2000	39574
Stepping cycles	39581
the movement pattern	39617
Rats from different groups	39657
Rats	39657
different groups	39667
the end of the experiment	39701
the end	39701
the experiment	39712
The locomotion pattern of normal rat 's stepping cycle	39728
The locomotion pattern	39728
normal rat 's stepping cycle	39754
normal rat 's	39754
a standard for comparison	39794
a standard	39794
comparison	39809
other rats	39825
different treatments	39841
the videotaped recordings	39876
a stepping cycle of uninjured rat	39903
a stepping cycle	39903
uninjured rat	39923
beginning , middle ,	39956
beginning	39956
middle	39967
phases	39986
a middle swing phase and a phase in stance -LRB- Fig. 2 -RRB-	39999
a middle swing phase	39999
a phase in stance -LRB- Fig. 2 -RRB-	40024
a phase	40024
stance -LRB- Fig. 2 -RRB-	40035
stance	40035
Fig. 2	40043
4.8	40052
Fast blue retrograde tracing The retrograde tracing with fast blue	40057
Fast blue retrograde	40057
Fast	40057
The retrograde	40086
fast blue	40114
neurons	40149
the cortex and brainstem with their axons	40160
the cortex and brainstem	40160
their axons	40190
the injury site	40239
3 or 22weeks after contusion injury	40255
3 or 22weeks	40255
contusion injury	40274
deep anesthesia with pentobarbital -LRB- 50mg/kg , i.p. -RRB-	40298
deep anesthesia	40298
pentobarbital -LRB- 50mg/kg , i.p. -RRB-	40319
pentobarbital	40319
50mg/kg , i.p.	40334
50mg/kg	40334
the wound	40350
the injury site	40378
One -LRB- 1.0 -RRB- μl of 2.0 % aqueous suspension of fast blue -LRB- Sigma , St. Louis , MO -RRB-	40407
One -LRB- 1.0 -RRB- μl	40407
One -LRB- 1.0 -RRB-	40407
One	40407
1.0	40412
2.0 % aqueous suspension of fast blue -LRB- Sigma , St. Louis , MO -RRB-	40423
2.0 % aqueous suspension	40423
fast blue -LRB- Sigma , St. Louis , MO -RRB-	40450
fast blue	40450
Sigma	40461
St. Louis	40468
MO	40479
the cord 1.5 mmcaudal to the injury site with one or two injections	40500
the cord 1.5 mmcaudal	40500
the injury site with one or two injections	40524
the injury site	40524
one or two injections	40545
a glass pipette attached to a 10 μlmicroinjector , which was fixed in a stereotaxic instrument	40576
a glass pipette	40576
a 10 μlmicroinjector , which was fixed in a stereotaxic instrument	40604
a 10 μlmicroinjector	40604
a stereotaxic instrument	40644
Seven days	40670
animals	40696
phosphate-buffered 4 % paraformaldehyde	40738
The brain and the cord	40778
The brain	40778
the cord	40792
post-fixed overnight at the same fixative	40818
post-fixed overnight	40818
the same fixative	40842
20 % sucrose in 0.1 M phosphate buffer	40885
20 % sucrose	40885
0.1 M phosphate buffer	40900
pH 7.4	40924
The whole brain including the brainstem	40933
The whole brain	40933
the brainstem	40959
a cryostat	40999
40 μm thick sections	41015
40 μm	41015
glass slides	41069
The samples	41083
a fluorescence microscope	41115
The position of each labeled neuron	41142
The position	41142
each labeled neuron	41158
each	41158
neuron	41171
order	41193
the same neuronmore	41217
once	41242
The labeled neurons in the motor cortex and nuclei in the brainstem related to the hind limb locomotion such as red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	41248
The labeled neurons	41248
the motor cortex and nuclei in the brainstem related to the hind limb locomotion such as red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	41271
the motor cortex	41271
nuclei in the brainstem related to the hind limb locomotion such as red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	41292
nuclei	41292
the brainstem related to the hind limb locomotion such as red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	41302
the brainstem	41302
the hind limb locomotion such as red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	41327
the hind limb locomotion	41327
red nucleus , lateral vestibular nucleus , reticular formation , raphe nucleus , and locus coeruleus	41360
red nucleus	41360
lateral vestibular nucleus	41373
reticular formation	41401
raphe nucleus	41422
locus coeruleus	41441
each rat	41485
4.9	41495
Histology and immunohistochemistry	41500
Histology	41500
immunohistochemistry	41514
perfusion	41553
the spinal cords	41564
the identical fixative overnight	41607
All spinal cords	41641
histological evaluation , i.e.	41677
histological evaluation	41677
i.e.	41702
the paraffin sections -LRB- 10 μmthick -RRB-	41708
the paraffin sections	41708
10 μmthick	41731
the middle of injury epicenter	41762
the middle	41762
injury epicenter	41776
hematoxylin and eosin , H.E.	41816
hematoxylin and eosin	41816
H.E.	41839
immunostaining	41876
the sections	41892
xylene	41928
a series of ethanols and distilled water	41953
a series	41953
ethanols and distilled water	41965
ethanols	41965
distilled water	41978
Sections	42003
the Antigen Retrieval Citra solution -LRB- BioGenex , San Ramon , CA -RRB- for 15 min	42027
the Antigen Retrieval Citra solution -LRB- BioGenex , San Ramon , CA -RRB-	42027
the Antigen Retrieval Citra solution	42027
BioGenex	42065
San Ramon	42075
CA	42086
15 min	42094
the endogenous peroxidase	42111
the sections	42137
3 % H2O2 in 50mM Tris-buffered saline containing 0.1 % Triton X - 100 -LRB- TTBS -RRB- pH 7.5 , for 30 min at room temperature -LRB- RT -RRB-	42170
3 % H2O2	42170
50mM Tris-buffered saline containing 0.1 % Triton X - 100 -LRB- TTBS -RRB- pH 7.5 , for 30 min at room temperature	42181
50mM Tris-buffered saline	42181
0.1 % Triton X - 100 -LRB- TTBS -RRB- pH 7.5 ,	42218
0.1 % Triton X	42218
100 -LRB- TTBS -RRB- pH 7.5	42233
100 -LRB- TTBS -RRB-	42233
pH 7.5	42244
30 min at room temperature	42256
30 min	42256
room temperature	42266
RT	42284
The normal goat serum -LRB- 2 % in TTBS -RRB-	42289
The normal goat serum	42289
2 % in TTBS	42311
2 %	42311
TTBS	42316
60 min at RT	42332
60 min	42332
RT	42342
the tissue	42349
blocknon-specific antigens	42363
incubatedwith primary antibodies diluted in TTBS with 1 % normal goat serum in a humidified chamber overnight at RT	42403
incubatedwith primary antibodies	42403
TTBS with 1 % normal goat serum	42447
TTBS	42447
1 % normal goat serum	42457
a humidified chamber overnight	42481
RT	42515
the sections	42519
1:200 biotinylated goat anti-mouse IgG -LRB- Jackson -RRB- for 60 min and then in 1:500 streptavidin peroxidase -LRB- Jackson -RRB- for 60 min in the same buffer	42561
1:200	42561
goat anti-mouse IgG -LRB- Jackson -RRB- for 60 min and then	42580
goat anti-mouse IgG -LRB- Jackson -RRB-	42580
goat anti-mouse IgG	42580
Jackson	42601
60 min and then	42614
60 min	42614
then	42625
1:500 streptavidin peroxidase -LRB- Jackson -RRB-	42633
1:500 streptavidin peroxidase	42633
Jackson	42664
60 min in the same buffer	42677
60 min	42677
the same buffer	42686
The immunoreactive product was visualized by incubating in 3,3 ′ - diaminobenzidine solution -LRB- DAB , 0.5 mgin 1 ml TTBS -RRB- with 0.01 % H2O2 for 1 -- 3 min .	42703
The immunoreactive product was visualized by incubating in 3,3 ′	42703
The immunoreactive product	42703
3,3 ′	42762
3,3	42762
diaminobenzidine solution -LRB- DAB , 0.5 mgin 1 ml TTBS -RRB- with 0.01 % H2O2 for 1	42767
diaminobenzidine solution -LRB- DAB , 0.5 mgin 1 ml TTBS -RRB-	42767
diaminobenzidine solution	42767
DAB , 0.5 mgin 1 ml TTBS	42794
DAB , 0.5 mgin	42794
DAB	42794
0.5 mgin	42799
1 ml TTBS	42808
0.01 % H2O2 for 1	42823
0.01 % H2O2	42823
1	42837
3 min	42839
3	42839
min	42840
The sectionswere rinsed , dehydrated ,	42845
The sectionswere rinsed	42845
hematoxylin	42936
Negative controls	42949
the lack of the primary antibody	42998
the lack	42998
the primary antibody	43010
The primary antibodies used for this study	43032
The primary antibodies	43032
this study	43064
monoclonal antibody against glial fibrillary acidic protein -LRB- GFAP , 1:1000 ; Neomarker , Fremont , CA -RRB- of astrocytes , monoclonal antibody against peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB- of Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB- , and monoclonal antibody against neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43079
monoclonal antibody	43079
glial fibrillary acidic protein -LRB- GFAP , 1:1000 ; Neomarker , Fremont , CA -RRB- of astrocytes , monoclonal antibody against peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB- of Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB- , and monoclonal antibody against neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43107
glial fibrillary acidic protein -LRB- GFAP , 1:1000 ; Neomarker , Fremont , CA -RRB-	43107
glial fibrillary acidic protein	43107
GFAP , 1:1000 ; Neomarker , Fremont , CA	43140
GFAP	43140
1:1000 ; Neomarker	43146
1:1000	43146
Neomarker	43154
Fremont , CA	43165
astrocytes , monoclonal antibody against peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB- of Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB- , and monoclonal antibody against neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43181
astrocytes	43181
monoclonal antibody against peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB- of Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB- , and monoclonal antibody against neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43193
monoclonal antibody against peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB- of Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB-	43193
monoclonal antibody	43193
peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB- of Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells -LRB- 1:100 ; Abcam , Cambridge , MA -RRB-	43221
peripheral myelin protein -LRB- P0 , 1:1000 ; courtesy of Dr. Archelos , Austria -RRB-	43221
peripheral myelin protein	43221
P0 , 1:1000 ; courtesy of Dr. Archelos , Austria	43248
P0	43248
1:1000 ; courtesy of Dr. Archelos	43252
1:1000	43252
courtesy of Dr. Archelos	43260
courtesy	43260
Dr. Archelos	43272
Austria	43286
Schwann cells , α-p75NTR antibody recognizing both OECs and Schwann cells	43298
Schwann cells	43298
α-p75NTR antibody recognizing both OECs and Schwann cells	43313
α-p75NTR antibody	43313
both OECs and Schwann cells	43343
OECs	43348
Schwann cells	43357
1:100 ; Abcam , Cambridge , MA	43372
1:100	43372
Abcam , Cambridge , MA	43379
monoclonal antibody against neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43406
monoclonal antibody	43406
neurofilaments -LRB- NF -RRB- -LRB- 1:200 ; Neomarker , Fremont , CA -RRB-	43434
neurofilaments -LRB- NF -RRB-	43434
neurofilaments	43434
NF	43450
1:200 ; Neomarker , Fremont , CA	43455
1:200	43455
Neomarker , Fremont , CA	43462
4.10	43487
Measurement of repaired tissue and lesion cavity Spared tissue is the remaining peripheral rim of spinal cord tissue	43493
Measurement	43493
repaired tissue and lesion cavity Spared tissue is the remaining peripheral rim of spinal cord tissue	43508
repaired tissue and lesion cavity	43508
tissue	43549
the remaining peripheral rim of spinal cord tissue	43559
the remaining peripheral rim	43559
spinal cord tissue	43591
the weight-drop contusion which also causes a central cord lesion cavity at the injury epicenter -LRB- Basso et al. , 1996 ; Beattie et al. , 1997 -RRB-	43624
the weight-drop contusion	43624
a central cord lesion cavity at the injury epicenter -LRB- Basso et al. , 1996 ; Beattie et al. , 1997 -RRB-	43668
a central cord lesion cavity	43668
the injury epicenter -LRB- Basso et al. , 1996 ; Beattie et al. , 1997 -RRB-	43700
the injury epicenter	43700
Basso	43722
et al. , 1996 ; Beattie et al. , 1997	43728
et al.	43728
1996 ; Beattie et al.	43736
1996	43736
Beattie et al.	43742
Beattie	43742
et al.	43750
1997	43758
The spared tissue	43765
fibers	43799
Figs. 5A , B	43828
Figs. 5A	43828
B	43838
tissue	43851
a newly formed tissue from the dorsal lesion cavity at the injury site	43861
a newly formed tissue	43861
the dorsal lesion cavity at the injury site	43888
the dorsal lesion cavity	43888
the injury site	43916
The repaired tissue	43933
structure from the normal cord tissue	43969
structure	43969
the normal cord tissue	43984
Schwann cells , some fibroblasts , newly formed blood vessels and regenerating axons -LRB- Zhang et al. , 2011b -RRB-	44038
Schwann cells , some fibroblasts	44038
Schwann cells	44038
some fibroblasts	44053
newly formed blood vessels	44071
regenerating axons -LRB- Zhang et al. , 2011b -RRB-	44102
regenerating axons	44102
Zhang	44122
et al. , 2011b	44128
et al.	44128
2011b	44136
the repaired tissue	44155
almost no astrocytes	44184
the changes of repaired tissues and lesion cavities in size , the whole area of spinal cord cross section at the injury epicenter , and the areas of spared tissues , repaired tissues and lesion cavities	44260
the changes of repaired tissues	44260
the changes	44260
repaired tissues	44275
lesion cavities in size	44296
lesion cavities	44296
size	44315
the whole area of spinal cord cross section at the injury epicenter	44321
the whole area	44321
spinal cord cross section at the injury epicenter	44339
spinal cord cross section	44339
the injury epicenter	44368
the areas of spared tissues , repaired tissues and lesion cavities	44394
the areas	44394
spared tissues , repaired tissues and lesion cavities	44407
spared tissues	44407
tissues and lesion cavities	44432
The paraffin sections	44486
hematoxylin and eosin	44526
the measurementwas	44552
each case with Soft Imaging System GmbH	44585
each case	44585
Soft Imaging System GmbH	44600
Version 1.20	44626
Olympus	44640
The average percentage of spared tissues , repaired tissues and lesion cavities to the whole area of cross section in each group	44650
The average percentage	44650
spared tissues , repaired tissues and lesion cavities to the whole area of cross section in each group	44676
spared tissues	44676
tissues and lesion cavities	44701
the whole area of cross section in each group	44732
the whole area	44732
cross section in each group	44750
cross section	44750
each group	44767
Mean ± SEM	44796
the comparisons between groups	44810
the comparisons	44810
groups	44834
4.11	44859
Collection of quantitative data of P0-positive myelination P0-positive myelin sheaths	44865
Collection	44865
quantitative data of P0-positive myelination P0-positive myelin sheaths	44879
quantitative data	44879
P0-positive myelination P0-positive myelin sheaths	44900
P0-positive myelination	44900
P0-positive myelin sheaths	44924
Schwann cells that can be found in the repaired tissue	44979
Schwann cells	44979
the repaired tissue	45014
the spared tissue at the injury site -LRB- Zhang et al. , 2011b -RRB-	45048
the spared tissue	45048
the injury site -LRB- Zhang et al. , 2011b -RRB-	45069
the injury site	45069
Zhang	45086
et al. , 2011b	45092
et al.	45092
2011b	45100
our previous study	45111
the quantitative data of P0 - positive myelination obtained from the injury epicenter	45131
the quantitative data	45131
P0 - positive myelination obtained from the injury epicenter	45156
P0	45156
positive myelination obtained from the injury epicenter	45160
positive myelination	45160
the injury epicenter	45195
the trend of axonal regeneration	45238
the trend	45238
axonal regeneration	45251
this purpose	45276
the number of P0-positive myelin sheaths	45290
the number	45290
P0-positive myelin sheaths	45304
the light microscope -LRB- magnification : 40 × -RRB- as described previously -LRB- Zhang et al. , 2011a -RRB-	45349
the light microscope -LRB- magnification : 40 × -RRB-	45349
the light microscope	45349
magnification : 40 ×	45371
magnification	45371
40 ×	45386
Zhang	45416
et al. , 2011a	45422
et al.	45422
2011a	45430
2 -- 3 histological sections with P0-immunostaining from injury epicenter of each case	45447
2	45447
3 histological sections with P0-immunostaining from injury epicenter of each case	45449
3 histological sections	45449
P0-immunostaining	45478
injury epicenter of each case	45501
injury epicenter	45501
each case	45521
the counting	45545
All P0-positive myelin sheaths in the repaired tissue , lesion cavity and spared tissue on the transverse sections at the injury epicenter	45559
All P0-positive myelin sheaths	45559
the repaired tissue , lesion cavity and spared tissue on the transverse sections at the injury epicenter	45593
the repaired tissue	45593
lesion cavity	45614
tissue	45639
the transverse sections	45649
the injury epicenter	45676
n ≥ 4 each group	45711
n	45711
≥ 4 each group	45712
≥ 4	45712
each group	45715
the spared tissue	45736
spared/demyelinated fibers and regenerating axons myelinated by Schwann cells -LRB- Zhang et al. , 2007a -RRB-	45766
spared/demyelinated fibers	45766
regenerating axons myelinated by Schwann cells -LRB- Zhang et al. , 2007a -RRB-	45797
regenerating axons	45797
Schwann cells -LRB- Zhang et al. , 2007a -RRB-	45830
Schwann cells	45830
Zhang	45845
et al. , 2007a	45851
et al.	45851
2007a	45859
the counting area	45867
the spared tissue	45894
all counted P0-positive myelin sheaths within the counting area	45921
all	45921
P0-positive myelin sheaths	45933
the counting area	45967
a total number for each case	46002
a total number	46002
each case	46021
The counts of P0-positive myelin sheaths in each group	46032
The counts	46032
P0-positive myelin sheaths in each group	46046
P0-positive myelin sheaths	46046
each group	46076
Mean ± SEM	46105
4.12	46115
Statistical analysis All quantitative data	46121
Statistical analysis	46121
All quantitative data	46142
Mean ± SEM	46182
field locomotor scores -LRB- BBB scores -RRB-	46197
field locomotor scores	46197
BBB scores	46221
the hind limbs	46237
the same group	46257
one score for each time point	46295
one score	46295
each time point	46309
The BBB scores	46326
a two-way analysis of variance -LRB- ANOVA -RRB- between any two groups and between the 6th week post-injury and the end of experiment	46361
a two-way analysis	46361
variance -LRB- ANOVA -RRB- between any two groups and between the 6th week post-injury and the end of experiment	46383
variance -LRB- ANOVA -RRB- between any two groups	46383
variance -LRB- ANOVA -RRB-	46383
variance	46383
ANOVA	46393
any two groups	46408
between the 6th week post-injury and the end of experiment	46427
the 6th week post-injury	46435
week	46443
the end of experiment	46464
the end	46464
experiment	46475
each individual group	46490
The areas of repaired tissue , lesion cavity and spared tissue	46513
The areas	46513
tissue , lesion cavity	46535
tissue	46568
percentage	46592
the whole area of the spinal cord	46606
the whole area	46606
the spinal cord	46624
the injury epicenter for each case	46643
the injury epicenter	46643
each case	46668
one-way ANOVAs	46683
comparison of repaired tissue , lesion cavity and spared tissue between groups	46716
comparison	46716
tissue , lesion cavity	46739
tissue between groups	46772
tissue	46772
groups	46787
All P0-positive myelin sheaths in the counting area of injury epicenter excluding the dorsal and ventral roots	46795
All P0-positive myelin sheaths	46795
the counting area of injury epicenter excluding the dorsal and ventral roots	46829
the counting area	46829
injury epicenter excluding the dorsal and ventral roots	46850
injury epicenter	46850
the dorsal and ventral roots	46877
the dorsal	46877
ventral roots	46892
each group	46938
the between-group comparisons	46950
one-way ANOVAs	47001
Neurons labeled with fast blue tracer	47017
Neurons	47017
fast blue tracer	47038
nuclei	47068
nuclei	47078
statistical analyses of differences between groups in the number of FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47086
statistical analyses	47086
differences between groups in the number of FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47110
differences	47110
groups in the number of FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47130
groups	47130
the number of FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47140
the number	47140
FB-labeled neurons -LRB- nuclei by nuclei and total -RRB-	47154
FB-labeled neurons	47154
nuclei by nuclei and total	47174
nuclei	47174
nuclei and total	47184
one-way ANOVAs	47222
all cases	47241
the analysis of quantitative data	47252
the analysis	47252
quantitative data	47268
overall significance followed by a post hoc LSD Student 's t test	47304
overall significance	47304
a post hoc LSD Student 's t test	47337
a post hoc LSD	47337
a post	47337
Student 's t test	47352
Student 's	47352
differences	47370
p	47413
Relationship between FBlabeled neurons from cortex and nuclei of brainstem and the BBB scores	47421
Relationship	47421
FBlabeled neurons from cortex and nuclei of brainstem and the BBB scores	47442
FBlabeled neurons from cortex	47442
FBlabeled neurons	47442
cortex	47465
nuclei of brainstem and the BBB scores	47476
nuclei	47476
brainstem and the BBB scores	47486
brainstem	47486
the BBB scores	47500
linear regression	47534
